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ABSTRACT
Protein aggregation occurs under many circumstances, from the dynamic
assembly of tubulin to form microtubules, the aggregation of actin into filaments, as well
as plaque formation by amyloid precipitation. One important requirement in studying the
mechanism of amyloid aggregation is the ability to monitor the growth kinetics over a
wide range in size scales (10 nm to microns) with time that spans microseconds to
seconds. Understanding the mechanisms of the aggregation may then lead to improved
design of drugs to help control or suppress the aggregation process.
In this dissertation, the physical characterization of the β-amyloid peptide and its
interaction with αα-amino acid peptide-based mediators was investigated from the early,
rapidly evolving stage to the later, slowly diffusing peptide stage by the application of
fluorescence photobleaching recovery (FPR). The diffusion rates of β-amyloid peptide
and β-amyloid assemblies under the effects of variables including concentration of βamyloid, blocker peptide, ionic strength, pH, time and temperature were accessible by
this method. In some instances, dynamic light scattering (DLS), which acquire signals
greater than 10 decades of lag times, without requiring a dye label was used for
comparison and to account for the limitations of any given approach. Attachment of 5carboxyfluorescein did not affect the integrity of the protein and the measured diffusion
coefficients were similar to those measured by diffusion ordered spectroscopy (DOSY)
and from theoretical expectations. FPR proved more sensitive than DLS for detection of
low oligomer aggregates of the β-amyloid peptide coexisting with much larger fibrils. We
were able to reverse the conformation of the peptide from the low oligomeric state to the

xvi

aggregated state under neutral and acidic pH conditions and confirmed that the peptide
growth increased with increasing ionic strength.
The interaction of β-amyloid peptide with membranes results in several
membrane-perturbing effects which may play a pivotal role in the pathogenic cascade
leading to Alzheimer’s disease. Model phospholipid bilayer membranes consisting of 1Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine (POPC) and 1-Oleoyl-2-[12-[(7-nitro2-1,3-benzoxadiazol-4-yl)amino] dodecanoyl]-sn-Glycero-3-Phosphocholine (18:1-12:0
NBD PC) were prepared on mica. FPR proved to be a useful technique for obtaining
information of the nature of membrane fluidity upon interaction with the β-amyloid
peptide.
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CHAPTER 1
INTRODUCTION
1.1 Proteins and Peptides
Proteins are macromolecules that are essential to the structure and function of all
living organisms. The primary structure of a protein consists of a linear chain of amino
acids linked by amide bonds. There are twenty standard amino acids, and it is possible to
create many unique sequences of very long chains of amino acids, resulting in proteins
with high molecular masses. Shorter chains with typically less than fifty amino acids are
called peptides. The function of proteins and peptides are dependent on their shape.
In order for proteins to perform their biological function, they must fold into the
correct higher order three-dimensional structures. The folding and unfolding kinetics of
proteins ranges from being fast (microseconds) and simple, with one single exponential
function of time1 to being slow (years). Regardless of the wide range of time frames,
proteins fold into complex shapes whereby minimum energy is used to maintain stability
in its native conformation. The ability of proteins to spontaneously fold into their lowest
energy native conformation depends on the interaction of their amino acid sequence with
environmental conditions like (solvent, pH, ionic strength, presence of other components
such as metal ions or prosthetic groups, temperature, and other).2 Pioneering studies by
Christian Anfinsen demonstrated that an unfolded protein (ribonuclease) could
spontaneously refold (by removal of certain chemicals or lowering the temperature) into
its native conformation in a test tube, thus concluding that proper protein folding is
primarily dependent upon the interactions of the amino acid sequence in a given
environment.

1

While normal physiological conditions predisposes the manner in which a
protein’s amino acid sequence folds into its native structure, there exists conditions
(extremes of pH, temperature) under which a protein will misfold or become unfolded.
Disruption in the normal protein folding pathway can result in potentially detrimental
consequences in the cellular environment. Incorrectly folded proteins that are essential to
normal cellular function may encounter difficulty in performing their biological function,
thus leading to malfunctioning of living systems and ultimately disease.3
Several human diseases are associated with the improper folding of proteins that
result in cellular malfunction.4 These include Alzheimer’s disease, Parkinson’, cystic
fibrosis, cancer and Tay-Sachs. While the exact mechanisms by which loss of function
occurs vary, researchers were able to categorize some diseases into three main groups –
defective proteins due to mutagenesis, amyloidosis and mislocalization. Mutations often
alter a protein sequence causing changes in the overall protein structure, which may result
in partial or complete loss of protein function. In contrast, amyloidosis results from the
accumulation of misfolded protein aggregations outside the cell forming insoluble
amyloid fibrils which have been associated with having a toxic function. A list of
diseases grouped according to mutant proteins and the associated molecular defect
appears in Table 1.1.5
Alzheimer’s disease (AD) is a neurodegenerative disorder and the leading cause of
dementia affecting majority of the elderly population. While neuropathologically, the
brains of individuals with the disease are characterized by insoluble extracellular amyloid
plaques and fibrils6, clinically, the disease progresses with gradual memory loss, changes
in behavior and disorientation. As the population ages, it is estimated that the number of
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Table 1.1 Some putative protein folding diseases (adapted from Ref. 5)
Disease

Mutant protein/protein
involved

Inability to fold
Cystic fibrosis

CFTR

Marfan syndrome
Amyotrophic lateral
sclerosis
Scurvy
Maple syrup urine disease

Fibrillin
Superoxide dismutase

Cancer

Collagen
α-Ketoacid dehydrogenase
complex
P53

Osteogenesis imperfecta

Type 1 procollagen pro α

Scrapie/Creutzfeldt-Jacob/
Familial insomnia
Alzheimer’s disease
Familial amyloidosis
Cataracts

Molecular phenotype

Misfolding/altered Hsp70
and calnexin interactions
Misfolding
Misfolding
Misfolding
Misassembly/misfolding
Misfolding/altered Hsp70
interaction
Misassembly/altered
BiP expression

Toxic folds
Prion protein

Aggregation

β-Amyloid
Transthyretin/lysozyme
Crystallins

Aggregation
Aggregation
Aggregation

Mislocalization owing to misfolding
LDL receptor
Improper trafficking

Familial
hypercholesterolemia
α1-Antitrypsin Deficiency
Tay-Sachs disease
Retinitis pigmentosa
Leprechaunism

α1-Antitrypsin
β-Hexosaminidase
Rhodopsin
Insulin receptor

Improper trafficking
Improper trafficking
Improper trafficking
Improper trafficking

people with the disease will continue to increase.7 Thus, development of therapeutic
targets for inhibition of the disease is of utmost importance. Despite rapid advances in the
research findings in the past decade, at the moment, there is no cure for the disease.
Nevertheless, researchers are continually striving to design new strategies for curbing the
progression of the disease.
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1.2 Aims of This Study
The main emphasis in this dissertation research is the use of fluorescence
photobleaching recovery (FPR) and dynamic light scattering (DLS) in the detection of the
early intermediates in protofibril formation and subsequently β-amyloid peptide selfassembly. This study will use β-amyloid1-40 (Aβ) and fluorescently (5-carboxyfluorescein) labeled β-amyloid1-40 mixtures at a variety of concentrations and
physiological conditions to determine the diffusion rates of β-amyloid peptide and βamyloid assemblies. The effects of variables including concentration β-amyloid, ionic
strength, pH, time and temperature are accessible by these methods. Following reliable
studies of the β-amyloid monomer association and aggregation, the physical properties of
‘inhibitor’ molecules, including, de novo peptide-based molecules designed by Robert P.
Hammer and their effectiveness at mediating amyloidoses was assessed.
Dynamic light scattering (DLS) was initially used to assess the earliest stages of
β-amyloid self-assembly. Monomeric Aβ, which is a 4KD peptide, scarcely scatters
above solvent level at the concentrations of interest. Thus, DLS in the early stage of Aβ
self-assembly proved challenging, but with a choice of powerful frequency doubled diode
and Argon ion lasers, a variety of detectors, and high-coherence single-mode fiber optic
detection as an option, signals could be obtained. Even so, and despite discriminating
custom software to analyze multiple runs in an efficient graphical fashion, distinguishing
the expected aggregates from dust remained a major issue. Moreover, aggregates were
sometimes present at low numbers in the detected volume, which leads to unwanted
number fluctuations. Taken together, these problems made it difficult to establish “clean
start” conditions to assess ‘inhibitor’ efficiency. It was decided that the best use of DLS
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was to screen inhibitor molecules for efficiency by testing their effect on larger
assemblies. To further establish “clean starting” conditions to study the effect of inhibitor
molecules on Aβ assembly, the dissociation of the peptide was monitored under high
pressure.
Fluorescence photobleaching recovery technique was a suitable alternative to
remediate the deficiencies of DLS from the standpoint of aggregation mechanism, despite
the requirement of having a fluorophore attached to the molecule of interest. FPR would
improve the economy of experimenting with the expensive Aβ peptide and inhibitor
molecules, in addition to addressing questions such as the reversibility of the Aβ peptide.
An in situ dialysis cell was designed and used to determine diffusion coefficients by FPR.
The diffusion coefficients were easily converted to size through Stoke’s law because the
system is very dilute. FPR was also used to assess the fluidity of lipid membranes upon
interaction with the Aβ peptide.

5

CHAPTER 2
BACKGROUND AND LITERATURE REVIEW
2.1 Cleavage of β-Amyloid Peptide from APP
It has been suggested that the accumulation of amyloid-β (Aβ) is the primary
influence driving AD pathogenesis.8;9 In 1984, Glenner and Wong10;11 reported the first
sequence of Aβ isolated from the principal protein component in AD brain. The Aβ
peptide was found to vary in length from 39-43 amino acid residues due to proteolytic
cleavage of the transmembrane glycoprotein, amyloid-β precursor protein (APP) by α, β,
and γ-secretases, as shown in Figure 2.1. The α-secretase cleaves APP within the Aβ
sequence producing soluble nonamyloidogenic fragments, which is a normal constituent
of human biological fluids,12 whereas cleavage by the β-secretase (extracellular, produces
the NH2 terminus), and γ-secretase (intracellular, produces the COOH terminus) releases
the toxic Aβ fragment from APP. The Aβ1-40 and Aβ1-42 are the predominant forms
and the peptide. The normal physiological function of APP remains uncertain, but it has
been shown that some possible functions may include cell proliferation13, cell adhesion14,
neurite outgrowth15, and neuronal migration.16
2.2 Properties of β-Amyloid Peptide
The term amyloid was originally used by German physician and scientist, Rudolf
Virchow, to describe proteinaceous aggregates associated with diseases as shown in
Table 1.1 because some of their properties resembled those of (amylase, cellulose)
starch.4;17 Virchow was able to recognize amyloid by tinctorial properties elicited when
amyloid-laden tissues were treated with iodine at the autopsy table.18 Later, amyloid
deposits were characterized by diagnostic staining methods, x-ray diffraction and electron
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microscopy to investigate the molecular structure of the fibrils. The early investigations
indicated that all amyloids, regardless of the disease involved or the source of the fibrils,
share the following morphological, tinctorial and structural characteristics19.
membrane
Amyloid Precursor Protein (APP)
C

N

Aβ Peptide

DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGV
β-secretase

α-secretase

γ-secretase

Figure 2.1 Schematic of β-amyloid (1-40) peptide location within the amyloid precursor
protein and it representative amino acid sequence.
(i)

the molecular structure of all amyloids is such that the fibrils bind Congo
Red and interact with the dye in such a way that it appears red
microscopically in normal light and has a characteristic apple green
birefringence20;21 under polarized light;

(ii)

in the electron microscope amyloid deposits can be seen to be composed
of uniform, straight unbranched fibers, approx. 10 nm in diameter and of
indefinite length – longer than 200 nm 22; the fibers are usually straight or
slightly curved which suggests they have a particularly rigid molecular
structure;
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(iii)

amyloid x-ray diffraction patterns show that the ordered, repeating
molecular structure of the fibrils consists of polypeptide chains in an
extended β-conformation, hydrogen-bonded together into sheets which run
parallel to the axis of the fibril and which have their constituent β-strands
arranged perpendicular to this axis, the so-called ‘cross-β’
conformation23;24. An x-ray diffraction pattern25 from paired helical
filaments (PHF) purified from Alzheimers’ patients cerebral cortex is
shown in Figure 2.2.

(iv)

amyloid protein aggregates were also found to be insoluble in common
solvents and detergents, and protease resistance.26
(a)

(b)

Figure 2.2 (a) X-ray diffraction pattern from a partially oriented, dried PHF pellet from
Alzheimer cerebral cortex.25 The beam was directed normal to the fiber axis, which is
vertical. The meridionally accentuated arcs at 0.476- nm spacing are indicated by the
arrowheads, and the equatorially accentuated arcs centered at about 1.06- nm spacing are
indicated by the arrows. (b) Schematic diagram summarizing the analysis of the x-ray
diffraction pattern from (a) indicating β conformation.23;24
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These early studies have now been extended by more detailed examinations of ex
vivo amyloid27 and synthetic amyloid28-30 with a range of techniques (mentioned below),
and it is now evident that while amyloids composed of different proteins belong to the
same class of substance, with similar or identical core structures, there are some
significant differences between them.
2.3 Literature Review
Many researchers are involved in understanding the role of β-amyloid peptide in
the pathogenesis of Alzheimer’s disease and designing strategies to prevent or slow the
disease progression. A wide variety of instrumental techniques, such as analytical
ultracentrifugation (AUC), dynamic light scattering (DLS), static light scattering (SLS),
diffusion-ordered spectroscopy (DOSY), circular dichroism spectroscopy (CD), electron
microscopy (EM), atomic force microscopy (AFM) and scanning force microscopy
(SFM), have been used to study the formation and aggregation properties of β-amyloid
peptide. The results from all these methods gave interesting insights into the mechanism
of amyloid formation and growth, but with the availability of new techniques, additional
progress will be made to enrich our understanding of the protein aggregation process.
This brief review of previous studies will highlight the strengths and limitations of
individual instrumental techniques used in the characterization of β-amyloid peptide and
cases when it was necessary to use a combination of techniques for comparison and to
augment the deficiencies of a given method.
Plaques that develop in the brains of Alzheimer’s patients are built up from fibrils
composed of hundreds or more β-amyloid peptide (Aβ) molecules.31 Thus, a central
question in the etiology of AD is the mechanism(s) by which these Aβ molecules are
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converted into plaque-associated fibers.32;33 Two instrumental techniques that have been
used to provide information about fiber formation34-37 and inhibition38;39 are dynamic and
static light scattering. Analysis of scattered light from particles in a solution illuminated
by a coherent light source provides a means for monitoring macromolecular association
in solution in real time.40 The data are heavily weighted toward larger particles; thus, the
method is most sensitive to the species of most interest-aggregated Aβ.
Pallitto et al. combined static and dynamic light scattering as a means to characterize
the interactions of several hybrid peptides with Aβ in solution. One advantage to using
light scattering was the fact that no probe molecules or labels that could potentially
interfere with Aβ aggregation was needed. Furthermore, quantitative information on
changes in the average size and morphology of particles is readily extracted from the
data. The DLS results of this study found that the best inhibitors as measured by
protection from toxicity, appeared to alter Aβ aggregation by increasing the rate of
aggregation. The inconsistency of this result was removed when SLS measurements
showed that the altering aggregate morphology was due to branching of the fibrils. That
is, the growth proceeded by consecutive association of Aβ onto the ends of existing
fibrils.41-43
Another instrumental technique that has been useful for providing information about
aggregate morphology is electron microscopy. Several studies have utilized EM to obtain
structural information about the fibril formation process.24;44-49 In a “seeded”
polymerization mechanism, a small amount of preformed amyloid fibrils is added to a
solution of Aβ peptide.20;50 It is believed that prior to fibril formation, oligomeric
intermediates must form. Early kinetic studies of Aβ fibrillization failed to detect any
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intermediate species.51 Thus, while EM is useful for visualizing changes in fibril
formation, it is difficult to quantify and provides limited information about the
aggregation process. Other methods that have failed to distinguish between fibrillar
morphologies of Aβ are turbidimetry and sedimentation. Although small oligomeric Aβ
species have been separated by analytical ultracentrifugation, (it was observed that at 450
µM, Aβ1-40 produces a slowly sedimenting species, which in addition to the rapidly
sedimenting, probably fibrillar material52 detailed structural information is still lacking.
This shortcoming was corrected by the use of AFM analysis, a technique providing
three-dimensional information about species adsorbed to surfaces without the need for
extensive sample preparation.45;53 Because AFM provides a three-dimensional
characterization of the fibril, it offers distinct advantage over traditional electron
microscopy.54 In a study by Harper et al., AFM was used to follow amyloid fibril
formation in vitro by the Aβ variants Aβ1-40 and Aβ1-42. Small elongated Aβ
oligomers, which was termed ‘protofibrils’, (possible intermediates in the assembly of
amyloid fibrils) was observed.55 It is difficult to decide whether the protofibrils are
assembly precurcors of the fibrils or whether the protofibrils are in fast equilibrium with
monomeric Aβ. This demonstrates a limitation of AFM to provide quantifiable kinetic
effects. An alternate technique would be fluorescence photobleaching recovery (FPR),
although the structural detail would be lacking.
Although FPR has never been used to study amyloid systems, a comparative
method, fluorescence correlation spectroscopy (FCS), has been used to overcome the lack
of selectively in light scattering.56;57 FCS detects spontaneous fluctuations in the
fluorescence emission of small molecular ensembles.56;58-60 Theoretical advantages of
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FCS are balanced by practical experimental advantages of FPR.61 Another self-diffusion
technique, pulsed field gradient NMR, has been used to study the extent of Aβ
aggregation; however, the methodology was deemed of limited utility for very large
aggregates due to unfavorable nuclear relaxation properties.62;63 Thus, FPR should be a
valuable complement to both FCS and pulsed field gradient NMR.
One important requirement in studying the mechanism of protein aggregation is
the ability to monitor continuously the kinetics of fibril growth and to identify the
intermediate stages of this process. Experimental data relating to the early stages of
amyloid aggregation are difficult to obtain.64 In an attempt to elucidate information about
the kinetics and different sizes spanning the range expected during peptide aggregation,
the experimental technique must be able to measure both rapidly and slowly diffusing
peptide aggregates. Fluorescence photobleaching recovery (FPR) is a well-established
technique for the measurement of diffusion coefficients. This study will investigate the
formation of β-amyloid aggregation at various stages by FPR, thus marking the first
application of the highly selective FPR method to amyloid research. It should prove a
valuable complement to additional characterization techniques that has been used to
determine the stability of the Aβ peptide aggregates.
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CHAPTER 3
EFFECT OF HIGH PRESSURE ON β-AMYLOID AGGREGATES
3.1 Introduction
High pressure has been known to cause conformational changes in proteins for
over a hundred years. In 1899, B. H. Hite reported the use of high pressure for milk (βlactoglobulin) preservation.65 Fifteen years later, P.W. Bridgman discovered that raw egg
(albumen, lysozyme) appeared cooked after high hydrostatic pressure treatment.66
Although few papers exist in the literature since the earliest studies, in the past
decade there has been a resurgence in the use of high pressure technology ranging from
understanding the fundamentals of protein disaggregation and refolding67-70, to
application in the food industry.71-73 High pressure is becoming an increasingly popular
biophysical technique for studying protein folding and structural dynamics; this is
important to gain insight into diseases associated with protein misfolding. The immense
interest in the food industry is due to adaptation of existing high pressure technologies for
utilization in both food preservation and preparation (processing and packaging of
materials). High pressure treatment may potentially preserve several properties of food
ingredients (color, flavor, nutritional value, texture, taste)72 with minimal effect on final
product quality. For example, high pressure treatment of milk inactivates the enzymatic
activity of microbes to prevent spoilage, in addition to enhancing the coagulation
properties of milk.71 In order to further exploit the use of high pressure technologies for
applications in biotechnology (protein therapeutics, design of novel vaccines and antiviral
drugs74), and the food industry (dairy, meats, and vegetables), it is paramount to
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understand the impact of high pressure on the structure and conformational changes of
proteins.
Several researchers have investigated the effect of high pressure on protein
structure and self-assembly properties. High pressure has been used successfully to
dissociate both oligomeric and complex-aggregated proteins. Paladini et al. reported that
hydrostatic pressure in the range of 1 bar – 3 kbar was able to dissociate proteins
(enolase, yeast hexokinase) from the oligomeric form into subunits.75;76 Much more
complicated protein systems (brome mosaic virus77 and mitochondrial ATP synthase78)
have also been dissociated with high pressure.79 High pressure treatment was shown to
reduce the aggregation rates of denatured proteins during refolding.67;80 St. John et al.
used high pressures (1-2 kbar) combined with low, nondenaturing concentrations of
guanidine hydrochloride (GdnHCl) as an alternative to strong chaotrophic salts to
disaggregate and refold proteins.70 Thus high pressure can eliminate the need for dilution
of reagents, buffer changes, or modification of reaction conditions.70;80
The mode of action of high pressure on protein dissociation has been
experimentally confirmed to depend on the penetration of water into the protein
matrix.68;81-86 Proteins have been found to contain small “free volumes” within their
folded conformation due to restrictions in amino acids proximity to each other. This
results in internal cavities and packing defects that make them sensitive to pressure.68
Application of high pressure disrupts the hydrophobic and electrostatic interactions
within the protein structure which results in a decrease in the volume of the system.67;72;84
Consequently, packing of solvent molecules is more efficient following protein
dissociation.
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Several amyloidogenic proteins aggregate into stable, predominantly β-sheet
fibrillic structures which are insoluble in common solvents.50;51 These protein aggregates
are implicated in several diseases. In Alzheimer’s disease, the β-amyloid (Aβ) peptide is
the major component of these aggregates. There is an urgent need for efficient methods to
hinder aggregate formation as this may lead to design of potential therapeutics.
Although significant progress has been made in understanding the mechanisms of
protein aggregate formation, several challenges remain. Among these, obtaining
reproducible starting materials (monomeric Aβ peptide) for biophysical characterization
has been of utmost priority. The existing chemical protocols to disaggregate the Aβ
peptide are time-consuming, and/or expensive; worse, the likelihood that some preseeded Aβ may still exist in the starting material cannot be ignored. As high pressure
treatment has proven to be a successful tool in dissociating proteins, it may help
circumvent some of these problems.
The objective of this study is to investigate the application of high pressure to
dissociate Aβ peptide into monomeric subunits. High pressure is a powerful, physical
method that has been shown to dissociate the amyloidogenic protein transthyretin, with
the possibility of achieving stable intermediates when pressure and temperature are
carefully “tuned”.68 The aggregation state of the Aβ peptide prior to experiment is critical
for obtaining reproducible results. This is particularly important when screening and
characterizing new peptides. Use of an inadequate array of biophysical techniques would
be costly overall. Thus, we used a high pressure system in order to obtain ‘stable’ Aβ starting
material for testing the efficiency of blocker peptides upon interaction with the Aβ peptide.
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3.2 Materials and Methods
•

Reagents and Chemicals
All reagents were of analytical grade. Hydrostatic liquid was spectroscopic-grade

ethanol with a low-fluorescence background signal. Distilled water was filtered and
deionized through a Millipore water purification system (18 MΩ resistance). βamyloid(1-40) (Catalog No. 24236) was purchased from Anaspec, Inc. (San Jose, CA).
Phosphoric acid (99.999%, Catalog No. 34,524-5) and semiconductor-grade potassium
hydroxide (99.99%, Catalog No. 30,656-8) were obtained from Aldrich Chemical Co.
Sodium chloride (99.999%, Catalog No. 10862) was obtained from Alfa Aesar. (2-[NMorpholino] ethane-sulfonic acid, MES) was purchased from Sigma (Catalog No. M8250).
•

Sample Preparation
The high pressure experiments were performed at two locations, identified as

Location A (UNICAMP, Sao Paulo, Brazil) and Location B (Louisiana State University,
LA). Both locations were equipped with similar high pressure system with the difference
being the information obtained. In Location A, the information obtained was the change
in light scattering intensity of the sample with response to increasing high pressure
(recorded with an Edingburg FL 900 spectrofluorometer). In Location B, the information
obtained was the change in size (radius) of the sample with response to increasing and
decreasing high pressure (recorded with a dynamic light scattering (DLS) instrument).
The β-amyloid1-40 (Aβ) samples (500 µM stock solution) were solubilized according to
the method of Aucoin.87 Briefly, stock solutions were prepared by dissolving the peptide
in filtered 10 mM KOH (pH 11) and vortexing with a Daigger Vortex Genie 2 until
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completely dissolved. The Aβ peptide is known to exist in a monomeric state under
sufficiently basic conditions.45 Otherwise, the stock was adjusted to the appropriate
concentration and pH values. In location A, the buffers used were 100 mM MES buffer at
pH 5.5 and 50 mM Tris chloride buffer, 150 mM NaCl, at pH 7.4. In Location B, several
buffers were used but the presence of large aggregates in solution exceeded the
capabilities of DLS. Results were obtained in the 50 mM phosphate buffered saline, 150
mM NaCl, pH 7.4 and 50 mM Tris chloride buffer, 150 mM NaCl, at pH 7.4.
•

Light scattering and fluorescence under pressure (Location A, UNICAMP, Sao
Paulo, Brazil)
The high-pressure system has been described elsewhere.88 An ISS model

(HPCell™, Champaign, IL USA) high-pressure cell with sapphire windows connected to
a pressure generator (HIP) was used. The intensity of light scattered at 340 nm was
recorded in an Edinburg FL 900 spectrofluorometer and was measured at an angle of 90°
relative to the incident light using the same wavelength for the excitation and emission
monochromators. The fluorescence data were obtained at an excitation wavelength of 280
nm and an emission of 290-400 nm.
The pressure system was automated and controlled by software denominated
“Automa” written in Delphi 5.0 language and compatible with Windows. A computer
controlled a series of devices, including: (1) a servomotor connected to an induction
motor that was coupled to the pressure generator, (2) the fluorometer monochromators
for excitation and emission, and (3) the step motors for the excitation and emission slits.
The software received information from a pressure gauge via an analog interface
connected to a 14-bit analog-digital board that allowed the control of pressure in real
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time, while data from the detectors were obtained via an RS232 serial port. All data were
processed in ASCII format and displayed on x-y plots.
•

Dynamic light scattering under pressure (Location B, Louisiana State University,
LA)
A similar setup as described previously was used for DLS with the exception that

the pump was manually operated. The light scattering instrument is described in Chapter
4. Details and photograph (courtesy of Rafael Cueto) of the set-up is provided in
Appendix B.
3.3 Results
•

Light scattering intensity results (Location A)
To examine the effect of pressure on Aβ aggregates, an initial sample of peptide

was prepared in MES buffer under conditions known to produce immediate aggregates.
Figure 3.1, (top) shows the effect of pressure on a 50 µM Aβ solution in 100 mM MES
buffer at pH 5.5. Light scattering showed a decrease of intensity with increasing pressure,
implying that the Aβ aggregates were being dissociated. Upon the return to atmospheric
pressure, the samples were inverted to check for precipitation of the sample at the bottom
on the sample cell, but no aggregates were observed visually. After about two hours at
atmospheric pressure, the same sample (Aβ run #1) was subjected to high pressure a
second time (Aβ run #2). The light scattering results followed an identical trend to the
first sample. The only intrinsic fluorophore present in the Aβ peptide sequence is the
aromatic side-chain of the tyrosine (Tyr 10) molecule. Although tyrosine has a low
quantum yield, its sensitivity was measurable by fluorescence spectroscopy.78 Thus, the
effect of pressure on the fluorescence of the sample was probed to ascertain whether
changes due to the tyrosine residues occurred. Figure 3.1, (middle) shows the
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fluorescence intensity response of the Aβ peptide to increasing pressure. After an initial
decrease in the fluorescence intensity, at pressures above 10,000 psi the fluorescence
intensity stabilized.
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Figure 3.1 Effect of pressure on the light scattering intensity and fluorescence properties
of β-amyloid peptide (Aβ). Top: light scattering intensity of an Aβ solution with a
concentration of 50 µM in 100 mM MES buffer, pH 5.5 subjected to high pressure.
Middle: Fluorescence properties of β-amyloid peptide solution in the top figure.
(figure continued)
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Figure 3.1 (continued) Bottom: Fluorescence emission spectra of Aβ solution in the
middle figure and corresponding plot of maximum fluorescence as a function of pressure.
The excitation wavelength was 280 nm. Each spectrum data was collected 5 minutes after
the pressure value had stabilized.
The increasing pressure had negligible effect on the tyrosine groups in the sample. This
suggests that perhaps there are no major structural changes in the microenvironment of
the fluorophore. The emission spectra characteristic of tyrosine groups as a function of
increasing pressure is illustrated in Figure 3.1, (bottom).
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To further test whether the Aβ peptide aggregates were being dissociated by high
pressure, the supernatant of the starting 50 µM Aβ solution in 100 mM MES buffer, pH
5.5 (collected after centrifuging the sample at 14,000 x g for 30 minutes) was subjected to
high pressure. Figure 3.2 (top) shows that the light scattering intensity is decreasing as a
function of pressure and leveled off at about 30,000 psi. The light scattering change is not
as dramatic as in Figure 3.1 (top), suggesting that further dissociation of the sample may
be due to the presence of minor amounts of aggregates in the solution. The light
scattering data of the Aβ supernatant solution is plotted with the aggregated sample for
comparison (Figure 3.2, bottom).
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Figure 3.2 Changes in light scattering of Aβ peptide as a function of pressure. Top: light
scattering intensity of an Aβ ‘supernatant’ solution with a concentration of 50 µM in 100
mM MES buffer, pH 5.5 subjected to high pressure.
(figure continued)
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Figure 3.2 (continued) Bottom: Superposition of light scattering data for both the
aggregated and supernatant Aβ solution. Each spectrum was collected 5 minutes after the
pressure value had stabilized.
After observing that it was possible to dissociate aggregated Aβ solution prepared
in MES buffer, a more ‘common’ buffer system was used. A fresh 50 µM Aβ solution in
50 mM Tris-Cl buffer at pH 7.4 was subjected to high pressure. Figure 3.3, top and
bottom shows the light scattering and the corresponding fluorescence intensity results
obtained. Both plots show similar trend in the light scattering and fluorescence intensity.
At low pressure up to 7,000 psi a sharp increase in the scattering and fluorescence
intensity was observed, followed by the opposite effect, namely a decrease in intensity at
higher pressures up to a value of about 17,000 psi. The experiment was terminated at this
pressure value due to technical problems (malfunctioning pressure gauge) with the
instrument.
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Although the instrumental problems mentioned above was solved, it turned out to
be ‘temporarily fixed’ as the problem recurred during acquisition of the data in Figure
3.4. The effect of high pressure on the light scattering intensity of Aβ in the presence of
Amy1 peptide was investigated. First, the light scattering of a 50 µM Aβ peptide prepared
in 50 mM Tris-Cl buffer, pH 7.4, under high pressure was monitored. The increase and
subsequent decrease in the light scattering intensity at low and high pressure respectively,
suggest that at low pressure the peptide’s structure is changing (increasing size) perhaps
due to interaction with the solvent molecules, while at higher pressure values the opposite
effect (decreasing size) may be due to dissociation of the peptide.
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Figure 3.3 Effect of pressure on the scattering and fluorescence intensity of β-Amyloid
peptide. Top: Light scattering intensity of 50 µM Aβ in 50 mM Tris-Cl buffer, pH 7.4.
(figure continued)
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Figure 3.3 (continued) Bottom: Fluorescence intensity of 50 µM Aβ in 50 mM Tris-Cl
buffer, pH 7.4.
The high pressure effect on the light scattering of the 50 µM Amy1 peptide prepared in
water was then monitored. The inset in Figure 3.4 shows an enhanced scale of the trend
in the scattering intensity of the Amy1 peptide under high pressure. The light scattering
signal remained uniform at both low and high pressure, implying that the Amy1 peptide
was stable under high pressure treatment. The sample containing a 1:1 molar ratio of Aβ
and Amy1 petide was then subjected to high pressure treatment. The general trend in the
data suggests that the combinded Aβ and Amy1 peptides were being dissociated, as the
light scattering intensity signal steadily decreased with increasing pressure. Additional
experiments could not be performed due to continued problems with the instrument’s
pressure gauge.
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Figure 3.4 Effect of high pressure on the light scattering of β-amyloid peptide and Amy1
peptide-based mediator. Inset shows adjustment of y-axis to show trend in the effect of
high pressure on the light scattering of 50 µM Amy1 peptide dissolved in water.
•

Dynamic light scattering results (Location B)
Although it would have been advantageous to measure the light scattering

intensity and corresponding size of the Aβ peptide, the instrument in Location A lacked
that capability. An opportunity to measure the effect of high pressure on the size of Aβ
peptide at a different location (Location B) was presented. The initial experiment to
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investigate the dissociation of Aβ aggregates prepared in MES buffer, as done at Location
A proved very challenging for dynamic light scattering as the aggregates were too large.
The alternate buffer choice used was 50 mM Tris-Cl, pH 7.4. Figure 3.5 shows the effect
of increasing and decreasing pressure on the hydrodynamic radius of Aβ peptide in TrisCl buffer. The initial hydrodynamic radius calculated was about 116 ± 4.0 nm. This value
very slightly increased to 148 ± 18 nm at the highest pressure of 35,000 psi. Upon
decreasing the pressure, differences between the initial and final radius of the sample was
negligible, suggesting stabilization of the sample. There was no substantial effect (within
experimental error) of high pressure on the size of the Aβ peptide in Tris-Cl buffer.
As most of the initial investigations of Aβ peptide were performed in phosphate
buffer, this buffer system was chosen (neglecting the effect of pressure on the buffer
itself) to study the effect of high pressure on Aβ peptide in this solvent environment. A
50 µM Aβ sample was subjected to high pressure in 50 mM PBS buffer, pH 7.4. Figure
3.6 shows the changes in hydrodynamic radius of Aβ as a function of increasing and
decreasing pressure. There is a steady increase in the radius of the peptide with increasing
pressure. At the highest pressure, the radius increased to 480 ± 4.3 nm, a difference of
about 100 nm from the initial radius (376 ± 1.8 nm) at atmospheric pressure. The radius
decreased to a value of 434 ± 3.2 nm at 10,000 psi and appeared to level off at 5,000 psi,
suggesting stabilization of the sample. One of the most likely explanations to the
increasing radius is that in the phosphate buffer environment, any dissociation of the Aβ
peptide induced by pressure is exposing the hydrophobic sites on the peptide to the
solvent, promoting interactions which leads to the observed increased in hydrodynamic
radius.
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Figure 3.5 Effect of high pressure on the hydrodynamic radius of Aβ. A 50 µM Aβ
sample subjected to high pressure in 50 mM PBS buffer, pH 7.4. Error bars are standard
deviation of triplicate runs.
The sample was kept at atmospheric pressure for one day and subsequently subjected to
high pressure. Figure 3.6, middle, shows the effect of high pressure on the radius of the
Aβ peptide after one day at atmospheric pressure following the first pressure cycle. The
peptide radii were identical with negligible error (standard deviation of triplicate runs)
during both the increase and decrease of pressure. A final radius of 325 nm was obtained
which is slightly smaller than the initial radius of 376 nm at the start of the experiment.
The results obtained for both pressure cycles of the effect of pressure on the radius of Aβ
are plotted for comparison (Figure 3.6, bottom).
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Figure 3.6 Dynamic light scattering results of increasing and decreasing pressure on βamyloid Aggregation. Top: Hydrodynamic radius plotted against increasing and
decreasing pressure. Middle: Hydrodynamic radius plotted against increasing and
decreasing pressure.
(figure continued)
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Figure 3.6 (continued) Bottom: Superposition of hydrodynamic radius for both cycles.
3.4 Conclusions
The main goal of this study was to use hydrostatic pressure to dissociate Aβ
peptide to obtain reproducible starting Aβ solution. The results obtained with light
scattering and fluorescence intensity measurements demonstrated that high pressure is an
efficient technique to dissociate Aβ aggregates and obtain stable material. For the effect
of high pressure on the size of Aβ peptide in both 50 mM Tris-Cl and 50 mM PBS, 150
mM NaCl, pH 7.4, the results did not show the expected trend corresponding to Aβ
dissociation. Rather, in the 50 mM Tris-Cl solvent environment, there was negligible
change in the size of the Aβ peptide for both increasing and decreasing pressure. In the
PBS environment, there was an initial increase in radius with increasing pressure and the
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opposite effect upon decreasing the pressure, with stabilization of the radius at low
pressures. Subjecting the Aβ peptide in the PBS environment to a second cycle of
increasing and decreasing pressures demonstrated that the sample had stabilized with no
changes in the peptide radius during both increasing and decreasing pressure.
The data in Figures 3.5 and 3.6 were measured at an angle of 90° at various
pressures, using a conventional dynamic light scattering instrument (modified for
accommodating the high pressure cell). As only a single angle was used, the
hydrodynamic radii represent apparent values. In both figures, the presence of large
aggregates at low and high pressure, were easily detected by DLS. Small aggregates were
not detected, but their presence could not be confirmed or denied; indicating one
limitation of DLS for preferentially detecting larger species. Nonetheless, the results
obtained using single angle measurements were adequate for observing any effect of high
pressure on the aggregation properties of Aβ. Overall, these results suggest that it is
possible to obtain stable samples (within the experimental time frame) of Aβ peptide
following high pressure treatment in PBS.
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CHAPTER 4
TECHNIQUES FOR MEASURING β-AMYLOID AGGREGATION
4.1 Introduction
Protein transport plays a critical role in how the mammalian central nervous
system communicates with the rest of the body. Important to the function of this
sophisticated transport system is the blood-brain barrier (BBB). If the structural
complexity of the system is ignored, the BBB can simply be described as a “gatekeeper”
of the central nervous system which regulates the passage of substances.89 Protein and
peptide ligand gain entry into or out of the brain and spinal cord by either simple
diffusion or saturable transport.89 An example of this concept is the transport of the βamyloid peptide (Aβ) out of the brain. It is believed that the normal function of the
transport system is to facilitate the removal of Aβ from the brain.90-92 Failure of the
transport system to clear the Aβ results in formation of amyloid plaque. Alzheimer’s
disease is a detrimental consequence of amyloid plaque accumulation in the brain. A
major goal is to understand the mechanisms of Aβ transport and plaque formation in an
effort to design therapeutic approaches to solve this problem.
While it is often a challenge to exactly emulate nature, scientists continue to find
ways to explore and answer many fundamental questions. For instance, fluorescence
photobleaching recovery (FPR) was originally developed to examine the dynamics of
living cells in vitro. The first application of FPR was geared towards understanding the
effect of membrane transport on the physiological states of cells.93-97 Recent reviews of
this technique describe the proliferation of this method as well as a host of applications.98105

Like FPR, dynamic light scattering (DLS) is also a powerful tool for studying
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molecular diffusion. The theory of DLS relevant to this study is described below.
Complete theoretical background of DLS can be found elsewhere.106-108
4.2 Theoretical Background
Mutual diffusion is a transport process in which there is a net flow of molecules,
normally from a region of high concentration to one of low concentration. Self diffusion
is also “natural” and does not involve the high-to-low change. Fick proposed that the
flow of matter along a concentration gradient should be analogous to the law of heat flow
along a temperature gradient.109 The product of diffusion coefficient and concentration
gradient is a measure of the flux and can be seen in the equation below, known as Fick’s
first law of diffusion:
J = - Dm (

dc
)
dx

(1)

where J represents the flux with units of square centimeter per second, c has
concentration units, and Dm is the mutual diffusion coefficient with units of centimeter
squared per second. The subscript represents mutual diffusion coefficient and it is the
diffusion coefficient obtained from measuring relaxation of the concentration gradient.
Diffusion depends on molecular size according to the Stokes-Einstein equation:

D=

kT
f

(2)

where k is the Boltzmann constant, T is the Kelvin temperature and f is the size-, shape-,
and concentration-dependent friction coefficient.

For a spherical particle with a

hydrodynamic radius Rh when dispersed at low concentrations in a solvent of viscosity
ηo, the friction coefficient is given by f = 6πηoRh. Translational diffusion can be used to
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determine the size and shape of individual molecules as well as molecular aggregates.
Dynamic light scattering is a useful technique for the measurement of motion of
molecules by the fluctuations in intensity. One measures the autocorrelation function of
the scattered light, g(1) (t), which contains information from its distribution of the
relaxation rate that can be used to determine molecular size. The decay follows a single
exponential profile:
g (1) (t) = e -Γ t

(3)

where Γ is the decay rate, proportional to the diffusion coefficient by:

Γ = q2 D m

(4)

in which q is the scattering vector magnitude, q = (4πn/λo) sin(θ /2), n is the refractive
index of the solution, λo is the in vacuo incident light wavelength and the scattering angle
is θ. A plot of Γ vs. q2 should be linear with a zero intercept and slope D. The apparent
mutual diffusion coefficient, Dapp = Γ /q2 is computed to test whether this is the case. A
plot of Dapp vs. q2 should be flat. Failure of Γ vs. q2 to rise linearly, or a slanted Dapp vs.
q2 plot, indicates particle heterogeneity and/or a shape other than spherical.

This

behavior can then be used to evaluate the apparent hydrodynamic radius, Rh,app of
molecules via the Stokes-Einstein equation:
Rh,app = lim

c→0,q →0

kT
6πηDapp

(5)

where k is the Boltzmann’s constant, and η is the solvent viscosity at temperature T.
In addition to the mutual diffusion, there exists a self-diffusion that also depends
on concentration, but self-diffusion happens even without a concentration gradient. Self-
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diffusion is a measure of the translational motion of a molecule.

The appropriate

relationship is due to Einstein and it appears in the equations below:
<x2> = 2Dst
Ds =

< x2 >
2t

(6)
(7)

The self-diffusion coefficient is referred to as optical tracer self-diffusion coefficient
when optical methods such as fluorescence photobleaching recovery experiments are
used to obtain it. The experimental setup for FPR is explained below. A distinguishing
factor observed between mutual and self-diffusion is that for mutual diffusion,
spontaneous or artificially created fluctuations help drive the diffusion from a region of
high concentration to one of low concentration, while for self-diffusion, the concentration
remains almost uniform. This behavior is observed because in FPR, the concentration of
the sample is proportional to the concentration of dye before bleaching a stripe pattern
into the sample. After bleaching, the concentration of the sample does not change, while
that of the dye changes due to diffusion. If the period of the pattern in the sample is L,
and the spatial frequency of the pattern is K, then:
K = 2π/L

(8)

In a FPR system equipped with modulation detector, a Ronchi ruling is translated
perpendicular to its stripes (bleached in the sample). Immediately after bleaching, the
maximum current at the detector represents a triangle wave, but the high harmonics fade
so quickly that the sharply defined pattern softens and approaches a sinusoidal wave
form. The contrast, C(t), of the stripe pattern, which is proportional to a voltage output
from the modulation detector system, decays exponentially:
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C(t) = C0e-Γt + B

(9)

The baseline, B, represents noise attributed to electronic jitter, imperfections in the cell,
or artifacts in the sample. The decay rate, Γ = DK2 where D is the tracer self diffusion
coefficient, K is the grating constant, and t is the time since photobleach. The diffusion
coefficient is obtained as the slope of Γ versus K2 plots of the data. Like DLS, the StokesEinstein relation, Ds = kT/(6πηRh) is used to obtain size information and is only valid at c
= 0, K = 0. Normally, it is safe to assume K = 0 in FPR, while taking the q = 0 limit in
DLS is much less secure.
4.3 Characterization Background of FPR
Fluorescence photobleaching recovery is a powerful diffusion tool used to
determine the physical properties of fluorescently tagged macromolecules. The theory of
FPR appears in detail in other sources.110-113 A brief summary of FPR is described.
The FPR apparatus is set up such that either a spot or fringed pattern is bleached
on the sample. In this work, only the modulated fringed pattern was used. The fringe
pattern is obtained from a Ronchi ruling (a coarse grating in which black stripes are
etched onto glass at uniform intervals) placed at the back focal plane of the microscope
objective lens. A short, intense bleach pulse (writing beam) with duration of less then
one-tenth of the recovery time irreversibly destroys about 5 to 10% of the fluorescently
labeled sample. After bleaching, a striped image resulting from the fringed pattern is
written in the sample. A weak continuous ‘reading’ beam subsequently excites the
unbleached fluorophores from the ground state to the first excited state. The recovery of
fluorescence due to redistribution of unbleached molecules into the bleached region of
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the sample is measured. The rate of recovery provides information about the diffusion of
the fluorescent molecules.
4.4 Instrumental Setup of FPR
The FPR apparatus is shown in Figure 4.1. The central component of the FPR is
an Olympus BH2 epifluorescence microscope whose illuminator assembly is modified to
allow illumination by a light source. The laser, either a Coherent Innova 90 argon ion
laser capable of producing 0.9 Watts at 488 nm or a Lexel EXCEL 3000 argon ion laser
capable of producing 0.9 Watts at 488 nm was used. The laser beam is passed through an
acousto-optic modulator (AOM, Newport Research N35085-3) driven by a modified
radio-frequency source (Newport Research 31085-6DS) which splits the beam into two
diffraction beams. The first-order diffracted beam, which is about 85% of the laser
output, is used for photobleaching. In this study, a fringed pattern is obtained by placing
a 1” Ronchi ruling (50, 100, 150, and 300 lines/inch, Edmund Scientific), cradled
between two loudspeakers (4” woofers – Radio Shack catalog number 40-1022B) that
face each other at the rear image plane of the microscope objective. The speakers are
driven in push-pull fashion by a low-frequency (typically 16 Hz) triangle wave whose
amplitude is adjusted to produce an oscillation one half the period of the ruling (or
multiples thereof). The input is shorted to stop the speakers during the photobleaching
step.
The patterned beam is deflected by a dichroic mirror and focused by the
microscope objective (4X, 7X, 10X, and 18X) onto the sample, which sits on a
temperature-controlled stage. An RCA 7265 photomultiplier tube (PMT) receives the
fluorescence from the sample. The PMT is protected by a shutter (Newport 846HP) that
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remains close during the photobleaching pulse.

The intensity readout from the

photodetector is fed to a Stanford Research Systems model SR560 low noise preamplifier
to filter out unwanted frequencies. The signal is then transmitted to both a Tektronic
221A 100-MHz digital oscilloscope (to monitor the quality of the sinusoidal wave
generated in the experiment) and an analog-digital card from National Instruments (# ATMI0-16D, Part #320489-01). The output signal of the A/D card is read by a Labview
generated program which analyzes the sine wave amplitude. The Labview program also
controls the switching of the AOM, the shutter, and the duration of signal collection. The
exponentially decaying contrast signal is then analyzed by all the usual analysis
methods—cumulants,114 single or multiple exponentials with floating baseline, and even
Laplace inversion115.
SCOPE
5-10% bleach depth
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TA/PVD *

PMT
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DM

L

longer
time
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Figure 4.1 Schematic of fluorescence photobleaching recovery experimental
setup(variant of the Lanni and Ware instrument) used in this lab. AOM=acoustooptic modulator; M = folding mirrors (an accommodation to space);
D=diaphragm (stray light reduction); RR=Ronchi Ruling; L= Lens (depends on
one’s microscope); DM=dichroic mirror; OBJ=Objective (4X – 40X; low N.A.);
(figure continued)
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S=Shutter; PMT=Photomultipler Tube; PA = Preamplifier; TA/PVD = tuned
amplifier/peak voltage detector. * indicates point of contact with computer
multifunction interface card.
4.5 FPR Experimental Protocol
One requirement of samples for FPR study is the attachment, preferably covalent,
of a fluorophore to the molecule of interest. It is important to choose a fluorophore that is
not easily photobleachable; on the other hand, the fluorophore should not be so stable that
it is barely bleachable. In the case of proteins, it is critical to establish that attachment of
a fluorophore does not affect the functioning of the protein. Once the sample has been
prepared, a very minute amount is required for doing FPR. The sample is typically loaded
in 0.1- or 0.2-mm-path-length rectangular microslides (Vitrocom) by capillarity, and the
microslide is flame-sealed.

A fluorescently labeled dextran is prepared to ensure that

the instrument is in working condition, particularly after focusing and alignment.
A sample data trace appears in Figure 4.2, along with the DC signal (equivalent to
a spot photobleach, but the depth is only about 5%). The quality of the decaying contrast
signal approaches that of a typical DLS correlogram after conversion to a first-order
correlation function. The inset of Figure 4.2 shows a plot of decay rate Γ vs. K2; the lack
of an intercept confirms the absence of nondiffusive (spontaneous or chemical) recovery
of the photobleached dye.
4.6 Characterization Background of DLS
When laser light is used to illuminate macromolecules, the electrons in the
molecules are induced to oscillate, due to the oscillating electric field of the light. As the
molecules will in turn radiate that light, the intensity of the scattered light will depend on
the magnitude of the dipole induced in the molecules.
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Figure 4.2 Modulation detector trace for aqueous FITC-Dextran (Sigma FD150). Top:
clean contrast recovery (AC) signal after only 5% photobleach of the original intensity,
DC. Middle: after baseline subtraction, semilogarithmic representation of a singleexponential behavior.
(figure continued)
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Figure 4.2 (continued) Bottom: decay rate scales linearly with squared spatial
frequency.
Thus, the larger the dipole induced, means the greater the intensity of the scattered light.
In solution, the random motion of the molecules will impart randomness to the light
scattered by these molecules. The relative position of two molecules will determine
whether the scattered light arriving at a particular position will interfere constructively
(higher intensity) or destructively (lower intensity). The combined intensity of light
scattered from several scattering molecules will vary in time, fluctuating around some
average intensity as the molecules move relative to each other. The rate of the
fluctuations is related to the rate the molecules are moving through the solvent. On a
short time scale, these fluctuations will be similar and correlated, thus; analyzing these
fluctuations can provide information about the molecule size.
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4.7 Instrumental Setup of DLS
A schematic of the DLS experimental set-up appears in Figure 4.3. The lasers
used were either a HeNe laser with wavelength of 632.8 nm or a Coherent Innova 90,
with wavelength of 488 nm. The device consists of a sample holder with an index
matching bath containing toluene. The sample is normally placed in 13 mm culture tube
or borosilicate glass cells (6 x 13 mm, Kimble) which is nearly isorefractive with the bath
solvent. The electronics consisted of a pulse amplifier/discriminator (PAD, Pacific
Precision model 126), a Hamamatsu R928p photomultiplier, and an ALV-5000 digital
multi-tau autocorrelator card installed in a personal computer. Measurements were made
at multiple scattering angles ranging from 30° to 110° by manually moving a detector
arm to each new angle needed.
Laser

Lens

Sample Cell

LASER
θ
Aperture

Photomultiplier
Detector

Correlator
Correlator
Computer
Figure 4.3 Schematic of dynamic light scattering experimental setup.
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4.8 DLS Experimental Protocol
Light scattering is very sensitive to large particles and does not distinguish them from
less interesting particles, such as dust or undissolved material.116 Measures are taken to
verify that the sample cell (13 mm culture tube) is clean by rinsing repeatedly with dustfree deionized water from a Barnstead Nanopure water purification system. The cleaned
tubes are then filled with the same ultrafiltered water and checked for any dust particulate
by viewing at 30 degrees in the light scattering system. Before the actual samples are
measured, an unimportant sample is measured to verify that the instrument is correctly
aligned, and in proper working condition.
In this case, a latex sample with an advertised diameter of 0.087 µm was used as a
reference. Figure 4.4 shows the dynamic light scattering results for the latex sample.
The calculated diameter of the latex particle was 0.089 µm which is in close agreement
with the advertised diameter. This shows that the instrument is almost perfectly aligned.
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Figure 4.4 Light scattering data for Latex particles. Top: Γ versus q2 plot.
(figure continued)
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Figure 4.4 (continued) Bottom: Apparent diffusion coefficient plotted as a function of the
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CHAPTER 5
USE OF FLUORESCENCE PHOTOBLEACHING RECOVERY AND DYNAMIC
LIGHT SCATTERING TO STUDY β-AMYLOID AGGREGATION
5.1 Introduction
The β-amyloid (Aβ) peptide is believed to play a causative role in the
pathogenesis of Alzheimer’s disease (AD).8;9;117;118 The exact mechanism through which
the Aβ induces its toxicity is still unclear. The conformational change from a random
coil/α-helix, soluble Aβ to a β-sheet fibrillic intermediate may be a crucial link in this
pathogenic cascade.52;119 Small aggregates (oligomers, protofibrils)18 were reported to be
more neurotoxic than the larger aggregates (fibrils).120 Several approaches to the
reduction of Aβ and its associated aggregates are under development.121 Challenges of
quantifying heterogeneous protein mixtures are key limitations of existing techniques.
Regardless of whether protofibrils or fibrils are responsible, it is certain that there is a
need for additional biophysical techniques to help solve this problem.
The main aim of this research was to apply new biophysical tools to characterize
the Aβ peptide aggregates and to test the behavior of the peptide in the presence of
mediators. Novel peptide-based mediators containing α,α-disubstituted amino acids
(ααAA), dipropyl glycine (Dpg), diisobutylglycine (Dibg) and dibenzyl glycine (Dbg)
were incorporated at alternating positions in peptide sequences forming the hydrophobic
core (KLVFF) of Aβ. These mediators, referred to as Amy1, Amy2 and modified-Amy
were designed with the idea that they would block amyloid fibril formation.
The observation that Aβ can bind a peptide fragment corresponding to the central
hydrophobic region of Aβ (16-20) and disrupt fibril formation122;123 underlies several
competing research efforts, including those mentioned above. Due to its ability to bind
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and prevent amyloid fibril formation without forming fibrils itself, the KLVFF fragment
of Aβ has been termed the ‘recognition element’. Several groups subsequently developed
inhibitor peptides with this recognition element and an additional ‘disrupter’ group to
either block hydrogen bonding or solubilize any Aβ-inhibitor byproduct. Soto et al.124;125
included proline residues (known β-sheet breakers) within the recognition element and
reported that the compound was able to prevent fibril formation, as well as partially
disaggregate preformed fibrils. Murphy et al.38;126 designed peptides with the sequence
(15-25) as the recognition element with the addition of hydrophilic poly(Lys) units as the
disrupting groups. They reported that their compounds were able to alter Aβ aggregation
by increasing the rate of protofibril assembly as well as blocked toxicity in vitro.
Meredith et al.127 designed inhibitors that contained N-methyl amino acids, and those that
replaced amide bonds with ester bonds in alternating positions within the recognition
element. They found that their compounds both blocked fibril formation and
disassembled preformed fibrils. It can be concluded that compounds containing both the
recognition element and disrupting groups are capable of altering Aβ aggregation kinetics
and morphology.
The ααAA-containing mediators were designed using Murphy’s inhibitors model
as a template. Previous work128-130 showed that ααAA had the ability to stabilize extended
peptide structural conformations. Fu et al.131 showed that peptides containing the Dbzg
residues at alternating positions were capable of adopting an extended conformation,
thereby preventing β-sheet formation. The peptide sequences of the Amy mediators are
shown in Scheme 1 below. Complete synthetic protocol of the Amy mediators has been
described.132;133
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Scheme 1: Code name and sequence of ααAA-containing peptide blockers of Aβ
assembly
AMY-1: H-Lys-Dibg-Val-Dbzg-Phe-Dpg-(Lys)6-NH2
AMY-2: H-(Lys)7-Dibg-Val-Dbg-Phe-Dpg-NH2
AMYB3: H-Lys-Aib-Val-Aib-Phe-Aib-(Lys)6-NH2

Scheme 2: Code name and sequence of modified ‘recognition element’ peptide blockers
of Aβ assembly
MURPHY: H-Lys-Leu-Val-Phe-Phe-Ala-(Lys)6-NH2
MEREDITH : H-Lys-Leu(Me)-Val-Phe(Me)-Phe-Ala(Me)-Glu-NH2

A combination of techniques was used to determine the stability of Aβ peptide
and kinetics of fibril growth in an attempt to identify the early and intermediate stages of
assembly. Physiological factors that induce the aggregation of soluble Aβ are of interest
in determining the cause of Aβ fibril formation.134 It is known that the peptide tends to
self-assemble under conditions of low and neutral pH (as a function of time). The peptide
remains in a monomeric or low oligomeric state at high pH values. The effect of variables
including concentration, ionic strength, pH and temperature were monitored.
Subsequently, the interaction of ααAA-containing peptide blockers with Aβ was tested.
5.2 Materials and Methods
•

Reagents and Chemicals
For this study, synthetic β-amyloid(1-40) and fluorescently labeled β-amyloid(1-

40) were obtained from Anaspec, Inc. San Jose, CA (catalog #’s 20698 and 23513).
Phosphoric acid (99.999%, Catalog No. 34,524-5) and semiconductor-grade potassium
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hydroxide (99.99%, Catalog No. 30,656-8) were obtained from Aldrich Chemical Co.
Sodium chloride (99.999%, Catalog No. 10862) was obtained from Alfa Aesar. The
filters used were from Whatman, 0.02 µm (Anotop 10, Catalog No. 6809-1102).
•

Sample Preparation
The biggest challenge in preparing β-amyloid samples is controlling the initial,

unaggregated state of the peptide. This is particularly important in order to understand
the early stages of amyloid aggregate formation. The presence of ‘seeds’ was reported to
greatly accelerate the aggregation of Aβ.54 To circumvent this problem, stock solutions
were prepared by dissolving the Aβ peptide in 10 mM aqueous potassium hydroxide.
This initial step was important as environments of high pH was found to produce ‘stable’
solutions of Aβ.87 The word ‘stable’ is taken to mean, not immediately forming
protofibrils when subjected to physiological phosphate buffer conditions; in other words,
the sample should be ‘non-aggregating’ for weeks.
Stock solution (500 µM) was prepared by dissolving the peptide in 10 mM
potassium hydroxide and vortexing until completely dissolved. In those instances where
the sample was difficult to solubilize, it was sonicated in a Branson Model No. 2510
sonicator. The sonication was done in five seconds cycles to prevent heat from affecting
the sample. An aliquot (20 µl) was removed for AAA and the remaining solution was
filtered through a 0.02 µm Whatman Anotop filter. Following filtration, an aliquot was
removed for AAA. A 10X phosphate-buffered saline (PBS), pH 7.4 (0.5 M phosphoric
acid, 1.5 M sodium chloride, 5 M potassium hydroxide) was filtered through 0.2 µm
Whatman Anotop filter, after which it was mixed with the desired volume of stock to
make final solutions of desired peptide concentration in 1X PBS, pH 7.4. Note that water

47

was first added to the peptide filtrate prior to adding the desired amount of PBS needed
for 50 mM, in order to prevent rapid disruption of sample in such high ionic strength.
Dilute solutions were made by adding buffer to the stock solution. The samples were
loaded in 0.2-mm-path-length rectangular microslides (VitroCom) by capillarity, and the
microslides were flame-sealed.
5.3 Results
5.3.1 Solution Properties of β-amyloid Peptide
•

Effect of variables on Aβ peptide aggregation
The application of fluorescence photobleaching recovery (FPR) and dynamic light

scattering techniques to the Aβ protein aggregation process are presented. In the case of
Aβ, it has been shown that labeling exclusively at the N-terminus of the peptide
minimizes modifications to the peptide conformation caused by the fluorophore’s
presence and preserves the original biological activity.135;136 The first experiment was to
determine the effect of varying bleaching time on the diffusion values of a solution
composed of 5-carboxyfluorescein labeled Aβ and mixtures of 5-carboxyfluorescein
labeled Aβ with unlabeled Aβ peptide. Figure 5.1 shows the diffusion coefficient as a
function of increasing bleach time at a laser power of 0.5 Watts. Both a plot for a 100%
labeled peptide and a 25/75 ratio labeled to unlabeled peptide at a concentration of 50
µM dissolved in 50 mM PBS, 150 mM NaCl, pH 7.4 are displayed. There is a slight
difference in the diffusion coefficient values obtained for the two samples; however, both
display decreasing diffusion coefficient values as a function of increasing bleach time. At
bleach times up to two seconds, the 100% labeled sample has slightly bigger diffusion
values than the mixed (25/75 ratio labeled to unlabeled peptide) sample, except at the
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highest bleach time of three seconds, where it is slightly smaller. It is evident (25%
difference in diffusion coefficient values from the initial bleach at 0.5 s to final bleach
time of 3.0 s) in the results that the increasing bleach times is causing changes to the
sample, however, it is difficult to attribute the decreasing trend in the diffusion values to
degradation of the samples due to heating by the laser. If cleavage of the fluorophore
occurred, then faster diffusion values representative of free dye would have been
expected. The smaller diffusion values suggest that some sort of binding or Aβ peptide
interaction may be more likely. These results indicate that care should be taken to avoid
high bleaching times as this affects the diffusion values of the peptide.
Figure 5.2, top and bottom shows a screen capture of the raw FPR data for the
100% labeled peptide (at the conditions above) bleached for 3.0 s (top) and 0.5 s
(bottom). Both conditions produced reliable diffusion coefficients. The arrow in each
figure demonstrates the DC signal before and immediately after the bleaching pulse. In
the top figure, about 50% of the sample is bleached and less than 10% in the bottom
figure. In the orginal and most common form of doing FPR experiments, very deep
bleaching (exceeding 50%) of a circular or Gaussian spot are required. In most of those
studies the samples measured are typically live cells or proteins. Apparently sample
damage due to prolong laser beam exposure has not hindered the use of this method. The
lack of defined boundary conditions for diffusion in Spot photobleaching may give rise to
partial photobleaching recovery. In heterogeneous samples where multiple diffusers are
present, the possibility that slow and fast diffusers may exchange on the same time scale
is highly likely and problematic. Shallow bleaches, typical 5-10% are sufficient in the
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modulation detector FPR system and this method is well-suited for analyzing
polydisperse systems.
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Figure 5.1 Diffusion as a function of bleach time of labeled and mixture of labeled and
unlabeled Aβ. The filled square symbol represents 100% 5-carboxyfluorescein Aβ1-40 and
the open circle symbol represents a mixture of 25% 5-carboxyfluorescein Aβ1-40 with
75% Aβ1-40 expressed as percentage of 50 µM peptide. Conditions: 50 mM PBS, 150 mM
NaCl, pH 7.4; laser power, 0.5 Watts. Error bars are standard deviations from triplicate
runs.
The effect of bleach time on the diffusion of Aβ peptide established that overheating during the photobleaching pulse may have potentially caused changes to the
overall sample integrity and caution should be taken to avoid over-bleaching. Next, the
effect of a fluorophore’s presence on the Aβ peptides’ normal property was examined.
Samples were prepared having different ratios of 5-carboxyfluorescein labeled to
unlabeled Aβ1-40.
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Figure 5.2 Representative raw FPR data for 100% 5-carboxyfluorescein labeled Aβ
bleached at 3.0 s and 0.5 s respectively. The x-axis is time and the y-axis is the contrast
(signal amplitude) for all plots. The arrows indicate the pre and post-bleach DC signal.
(A) Linear-Linear scale representation. (B) Information about the sample file. (C)
Logarithm-Linear scale representation and (D) Linear-Logarithm scale representation.
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These samples were measured and compared to 100% labeled Aβ1-40 as a test that
attachment of a probe had little effect on the sample properties. Figure 5.3 shows the
diffusion coefficient of the 100% labeled sample was within error of that measured in the
mixed samples, indicating that the dye moiety does not itself preferentially interact with
unlabeled Aβ1-40 molecules. In the studies done with a mixture of labeled and unlabeled
Aβ1-40 peptide, a ratio of one to three or twenty-five to seventy-five percent labeled to
unlabeled peptide was used, mostly to compensate for any given strength of the laser
power. If a protein is purchased fully labeled, cutting in some unlabeled material may
prove useful98 and practical if the labeled peptide is three times as costly as the unlabeled
peptide.
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Figure 5.3 Diffusion as a function of dyed to undyed Aβ, expressed as percentage of 50
µM 5-carboxyfluorescein Aβ1-40 mixed with 50 µM Aβ1-40 Conditions: 50 mM PBS, 150
mM NaCl, pH 7.4. Error bars are standard deviations from triplicate runs.
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•

Effect of Concentration on Aβ Assembly
The kinetics of Aβ aggregation are known to depend on the peptide concentration,

pH and ionic strength.137-141 In addition, negligence in sample preparation such as
impurities in the sample containers, surface roughness of sample containers,
introduction of salt, metal ions, and contact with metals can all induce aggregation.87
The effect of concentration on the diffusion coefficient of Aβ samples was examined.
Figure 5.4 shows the effect of increasing concentration on the diffusion coefficient of
75/25 % labeled to unlabeled Aβ peptide in 10 mM KOH. The samples were
measured on three consecutive days, stored in a dark chamber, and measured again on
the twenty-sixth day following sample preparation. As Aβ peptide was observed to be
non-aggregating at high pH, no concentration dependence on the diffusion coefficient
of the peptide was expected and none was observed.
The diffusion coefficients at each concentration and at the given times measured are
almost identical within experimental error. The slight decrease in the diffusion coefficient
measured on day 2 may be attributed to variation in measuring conditions, such as
increased laser intensity or bleached time. The measurement on day 26 was done at a
different objective setting and consequently spatial frequency value in an attempt to
improve the signal quality. Improvement in the signal quality does not however explain
the faster diffusion values obtained on day 26. At instances where the Aβ was bleached
too deeply, slower diffusion values resulted, thus the most likely explanation for the
faster diffusion values may be attributed to stabilization of the sample due to the presence
of the 5-carboxy-fluorescein fluorophore. The dye may be hindering the Aβ peptide’s
ability to self associate with a likely consequence being contraction of the peptide.
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Figure 5.4 Effect of concentration on the diffusion coefficient of 75/25 % labeled and
unlabeled Aβ peptide. The samples were measured on three consecutive days and stored
for a period of time and measured again on the twenty-sixth day following sample
preparation. The filled circles represent data from day 1. The open circles represent data
from day 2. The open upside-down triangles represent data from day 3. The filled
triangles represent data from day 26. Conditions: 10 mM KOH, (Ronchi Ruling = 50
lines per inch; objective = 4X, K = 157 cm-1 and objective = 7X, K= 253 cm-1).
•

Effect of pH and Ionic Strength on Aβ Assembly

FPR measurements were made on samples containing 25% labeled and 75% unlabeled
peptide at three pH values, spanning the range where the peptide is believed to exist in
the high-to-low oligomeric states. Figure 5.5 shows diffusion coefficient results for a
mixture of labeled and unlabeled Aβ (100 µM in 50 mM phosphate buffer at pH 2.7, 6.9
and 11) over a one month period. The diffusion values are consistent with theoretical
predictions.63 They also match experimental values for monomeric β-amyloid1-40
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measured elsewhere using diffusion ordered NMR spectroscopy.62 These results
demonstrate that attachment of a dye does not radically alter the hydrodynamic size of the
peptide; however, these findings are perplexing as the β-amyloid1-40 peptide is widely
thought to aggregate at neutral and lower pH values. Smaller values of diffusion
coefficient might have been expected as the Aβ1-40 peptide was thought to aggregate
within the experimental time frame at neutral pH. One possibility is that the 5-carboxy
fluorescein dye attached to the peptide is contributing to its stability. Figure 5.6 shows
the corresponding semilogarithmic plot for representative data demonstrating almost
single exponential characteristic of a monodisperse sample.
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Figure 5.5 Trend of pH effects on the diffusion coefficient of Aβ. Conditions: sample was
composed of a 100 µM 25/75 % mixture of labeled and unlabeled Aβ in 50 mM PBS, 150
mM NaCl at pH ► 2.7, ○ 6.9, and ■ 11. The error bars are standard deviation of triplicate
runs.
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In order to further explore possible explanations for the results in Figure 5.5, it
was necessary to perform additional experiments. While repeating the experiment with a
fresh stock of peptide would have been best (that was done and those results are
discussed below), it was simpler to verify that the peptide was capable of assembling by
varying a condition known to induce aggregation. One such condition is the presence of
high concentrations of salts in the aqueous solution.142 FPR measurements were made on
100 µM Aβ samples containing 25% labeled and 75% unlabeled peptide in different
concentrations of sodium chloride environments. The effect of added sodium chloride on
the diffusion coefficient of the Aβ sample was monitored. At low salt concentrations,
only one decay mode was observed.
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Figure 5.6 Semilogarithmic FPR traces for three Aβ samples at different pH values. After
baseline subtraction, each semilogarithmic representation highlights the almost single exponential
characteristic of a monodisperse sample. Conditions: 100 µM 25/75 % mixture of 5-

carboxyfluorescein Aβ and unlabeled Aβ in 50 mM PBS, 150 mM NaCl at pH values ►
2.7, ○ 6.9, and ■ 11.
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At ionic strengths of 100 µM up to a sodium chloride concentration of 200 µM, double
exponential behavior was observed. Subsequently, the effect of pH on Aβ aggregation
experiment was repeated using a fresh batch of only labeled Aβ.

6.0

Fast Decay
Slow Decay

D/ 10-9 cm2s-1

5.0

4.0

3.0

2.0

1.0

0.0
25

50

75

100

125
-3

150

175

200

-1

[NaCl]/ 10 mol-L

Figure 5.7 FPR measurements on samples containing 100% 5-carboxyfluorescein-labeled
peptide in 50 mM PB, at pH 7.4 with increasing sodium chloride concentrations. The
monomeric diffusion coefficient of Aβ(1-40) was found to be 1.58 x 10-6 cm2s-1.
In Figure 5.8 are shown results for labeled Aβ1-40 peptide at three different pH
values (► 2.7, ○ 6.9, and ■ 11). The diffusion coefficient values at pH 6.7 and 11 were
almost identical, (as observed in Figure 5.5 with the mixed Aβ sample), and remained
constant over a period of two weeks. At pH 2.7, the diffusion coefficient did decrease
significantly with time. When this result is converted to diameter via the Stokes-Einstein
equation (Dh = kT/6πηR, where η represents the viscosity), one finds an enormous
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increase in hydrodynamic diameter from about 2.6 nm to about 860 nm. This observation
correctly indicates the ability of FPR to follow a very wide range of diffusers. The
decreases in diffusion in Figure 5.8 do not fully reflect the presence of macroscopically
large aggregates that were visible immediately after lowering the pH.
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Figure 5.8 Diffusion of 100 µM 5-carboxyfluorescein Aβ1-40 (100% labeled) in 50 mM
PBS, 150 mM NaCl, pH values, ► 2.7, ○ 6.9, and ■ 11. Error bars are standard
deviation of triplicate runs.
A fluorescence microscopy image of the aggregated peptide (100 µM 5carboxyfluorescein Aβ1-40, 50 mM PBS, 150 mM NaCl, pH 2.7), is shown in Figure 5.9a,
accompanied by an image of the stripe pattern in Figure 5.9b. Visible aggregates are
present throughout, but they are not uniformly distributed; thus, the measured diffusion
can vary within the sample cell, depending a little on the position chosen for
measurement. One advantage of FPR is that one may choose visually to measure regions
that do not possess extraordinarily large aggregates. If the striped pattern were to
illuminate regions with many of these very large aggregates, the recovery of the signal
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would be incomplete on the time scale of observations in this study. Very long
observations might then reveal the rate of exchange of molecules into and out of the very
large aggregates and or very slow diffusion along the fibrils.
(a)
(b)

Figure 5.9 (a) Fluorescence microscopy image of 100 µM 5-carboxyfluorescein Aβ1-40 in
50 mM PBS, 150 mM NaCl, pH 2.7. (b) microscopy image of Ronchi ruling stripe
pattern in labeled gelatin.
The log-log curves of Figure 5.10a, demonstrate the effectiveness of FPR as a tool
to detect simultaneously both the large, slow diffusers and the small, fast ones within a
given sample. Over 99% of the contrast was relaxed in these measurements, indicating
that immobile fragments were avoided. Even in cases where a large fragment is
illuminated, such that the recovery levels out after some time, it is possible to determine
the size of the mobile fraction by treating the immobile fraction as a baseline term during
analysis.
Further analysis of the data curves in Figure 5.10a, was done by estimating the
inverse Laplace transform, ILT, using an adaptation of Provencher’s143;144 CONTIN
program. The corresponding CONTIN distributions of the data are shown in Figure
5.10b.
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Figure 5.10 (a) Log-log FPR traces for Aβ samples at three pH values. After baseline
subtraction, each semilogarithmic representation highlights double exponentiality
characteristic of a polydisperse sample. Conditions: 100 µM 25/75 % mixture of 5carboxyfluorescein Aβ and unlabeled Aβ in 50 mM PBS, 150 mM NaCl at pH values ►
2.7, ○ 6.9, and ■ 11. (b) CONTIN distributions of data in (a).
(figure continued)
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Figure 5.10 (continued) (c), (d), screen capture of the overlay of data, multiple
exponentials and CONTIN. The roman numerals indicate: (I) simulated diffusion data,
(II) ILT from CONTIN, (III) exponential analysis, (IV) error in CONTIN amplitude, (V)
residuals of ILT calculated in CONTIN.
(figure continued)
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(e)

Figure 5.10 (continued) (e), screen capture of the overlay of data, multiple exponentials
and CONTIN.
The major peak at pH 11 indicates that the majority of the diffusing species are
narrowly distributed. The major peaks corresponding to pH 2.7 and 6.9, demonstrates
slightly broader peaks than that of pH 11, with one (pH 6.9) and two (pH 2.7) additional
smaller peaks. The broader peak represents the diffusion of the fast molecules, while the
smaller peaks are assigned to the slowly diffusing species. The well-defined CONTIN
peaks were an indication of the size range of the various species in solution. These results
indicate that each pH environment induced different aggregation properties of the Aβ
peptide.
Figure 5.10 (c), (d), and (e) displays CONTIN fits with compressed data and
overlaid exponential fits corresponding to the decay behavior of single (c, pH 11) and
multiple diffusers (d, pH 6.9, and e, 2.7). In Figure 5.10c, for the single diffusing species
at pH 11, the average decay rate obtained by the ILT agreed with the single exponential
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result (indicated by magenta vertical line dissecting the major peak). A fast diffuser with
narrow distribtution and large error bars is evident in both Figure 5.10c and d. This can
be attributed to failure of the beginning data points to follow the trend in the exponential
analysis. In Figure 5.10d, the fast decay mode of the ILT distribution failed to overlay
with the results from triple exponential analysis. This suggests that a double exponential
analysis would fit the data best. In Figure 5.10e, almost perfect agreement between the
overlay of the ILT and triple exponential analysis is demonstrated.
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Figure 5.11 Effect of temperature on the aggregation properties of Aβ peptide.
Conditions: 100 µM Aβ in a 100 mM PBS, 150 mM NaCl, pH 7.4.
•

Effect of Temperature on Aβ Assembly
The effect of temperature on Aβ assembly was also investigated. Figure 5.11

shows the response in diffusion coefficient values as a function of increasing
temperature. The high temperature was expected to induce the self-assembly of the Aβ
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peptide. The results indicate that only a fast and slowly diffusing species were present
from the initial physiological temperature, and the duration of the experiment.
The trend in the diffusion coefficient implies that perhaps the Aβ sample had stabilized
and the increasing temperature did not affect the structural integrity of the peptide.
5.3.2 Development of a Convenient Tool to Study β-amyloid Assembly
•

Dialysis fluorescence photobleaching recovery
It was demonstrated that FPR was able to successfully characterize Aβ peptide.

The sensitivity of this technique made it possible to distinguish between the sizes of
several species in a heterogeneous solution. To further improve the economy of
experimenting with the expensive ($640/mg) 5-carboxyfluorescein (labeled) Aβ and to
test the efficacy of mediator peptides, an in situ FPR dialysis cell was developed.145 The
advantages of this set-up include simplified studies on the effect of salt and pH on Aβ
aggregation, as well as addressing the reversibility of the peptide in solution.
A schematic of the constructed dialysis FPR cell is shown in Figure 5.12. The
housing (a top cover and a bottom chamber) of the cell was fabricated from PTFE. A
mini peristaltic pump (Crouzet, France) with a motor speed of 60 rpm was used to
circulate the exchange fluid through the subchamber from a 250 mL filter flask at a rate
of about 20 mL/min. The microscope viewing piece was constructed with round
microscope cover glass that was bonded for about 24 h at room temperature, under
modest pressure, to an etched Teflon sheet with a thickness of 0.3 mm (Small Parts, Inc.)
using Super Glue (a fast-curing cyanoacrylate formulation, Walmart). The dialysis
membrane (Spectrum® Laboratories Inc. Spectra/Por #7) that forms the semi-permeable
partition between the sample and exchange fluid had a 2000 Da MWCO. To prepare the
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set-up, typically 250 µL of sample is sandwiched between the microscope viewing piece
and the dialysis membrane. The inside of the bottom chamber (area underneath the
dialysis membrane) is filled with 15 mL of the exchange fluid. When the dialysis housing
is closed, the dialysis membrane is pressed against the etched Teflon space and in turn
against the cover glass and the bottom chamber, using O-rings. The large dialysis area (~
0.65 in.2), together with the thinness of the sample, about 0.3 mm, facilitates rapid
dialysis.

Cover slip
Sample
PTFE spacer
Dialysis membrane
O-ring

Pump

Exchange Fluid

Figure 5.12 Schematic and photograph of the dialysis FPR cell.
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The kinetics of Aβ aggregation was monitored by dialyzing 50 µM of labeled Aβ
sample against 10 mM citrate buffer at pH 5.0. The sample was initially solubilized in 10
mM KOH. Figure 5.13 shows the slow decline in diffusivity of Aβ under exposure to the
weak citrate buffer. After about 1 hr, a slow diffuser appears, representing assemblies
with a hydrodynamic radius of about 23 nm. This larger species, which accounted for
about 18% of the Aβ present, would have been expected to grow to many times larger in
time. This growth was not observed due to a problem with the dialysis cell. The problem
commonly encountered is that the microscope cover glass tends to crack with prolonged
dialysis. This may be attributed to the fragility of the glass or perhaps as a result of
changes in the pressure of the system.
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Figure 5.13 Evolution of protofibrils from labeled monomer after dialysis against a weak
citrate buffer at pH 5.0. After ~ 1hr, large aggregates appear and represent about 18% of
the signal.
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The dialysis of Aβ against citrate buffer demonstrated that it was possible to
change the size of the peptide in a relatively short period of time. Thus, an alternate
buffer in which the aggregation of the peptide was ‘delayed’ or rather, representative of
typical growth kinetics of the peptide (where rapid aggregation was not induced) was
desired. To achieve this, a new sample, composed of 50 µM labeled Aβ in 10 mM KOH
was dialyzed against 100 µM Acetate buffer at pH 4.0. Figure 5.14 shows the time
response of the diffusion coefficient of the peptide after first dialyzing against acetate
buffer, followed by the addition of increasing concentrations of calcium chloride, 0.1 N
HCl, and finally 50 mM phosphate buffer, pH 7.2. Both fast and slow diffusers were
present after about 30 mins of sample dialysis. This was indicated by the biexponential
analysis of the data. There was a slight decrease in the diffusion coefficient values, but,
after 19 hrs of dialysis, the diffusion coefficient was almost identical within experimental
error, to the initial diffusion coefficient value. The trend in the diffusion coefficient
suggested that the aggregates had stabilized; otherwise the diffusion values would have
been expected to continue to decrease after the first 5 hrs of dialyzing. At this point, it
was best to change the course of the experiment.
Several choices were possible, but the effect of calcium chloride on the Aβ
species present in solution was investigated. The required amount of CaCl2 corresponding
to 5 mM was added to the dialysis fluid and the sample was dialyzed for about 1 hr. The
diffusion coefficient response remained biexponential and decreased with increasing
calcium chloride concentration, up to 15 mM. After addition of 25 mM calcium chloride
to the dialysis fluid, the diffusion coefficient remained almost identical to that obtained
for 15 mM. The sample was dialyzed for an additional 2 hrs and measured again. The
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diffusion coefficient value increased slightly higher than that obtained with 15 mM
CaCl2, but overall, still smaller than when the sample was dialyzed against acetate buffer.
The addition of CaCl2 (up to 15 mM) facilitated the aggregation of Aβ. Additional CaCl2
(up to 25 mM), suppressed this effect and appeared to instead dissociate the Aβ
aggregates. The reason for this is not obvious but can be explained as a change in the pH
of the dialyzing solution due to the addition of calcium chloride. It can be proposed that
calcium chloride binds certain amino acid residues in the Aβ peptide. Increasing the
calcium chloride concentration may have created slightly acidic pH conditions which
perhaps destabilized the aggregates. This can be compared to the effect of the divalent
metal Zn(II) on Aβ aggregation. Zn(II) was found to promote Aβ aggregation at normal
pH while suppressing Aβ aggregation at slightly acidic pH conditions.146 At this point in
the experiment it appeared that the formation of aggregates was sequestering the
fluorophore. This was evident by a significant loss of fluorescence in the sample and the
appearance of black (non-fluorescent) aggregates. One explanation why the sample had
become difficult to bleach may simply be that with extensive dialysis, any source of
oxygen present in the sample had become depleted. The pH of the sample was adjusted
with 0.1 N HCl, to a final pH of about 1. The sample was dialyzed for almost 17 hrs and
subsequently measured. The sample had regained full fluorescence intensity and
apparently the biexponential nature had disappeared and the diffusion coefficient was
now a single exponential value. The dialysis fluid was then exchanged with 50 mM
phosphate buffer, pH 7.2. The diffusion coefficient remained single exponential and
increased to a value higher than that of the 0.1 N HCl.
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Figure 5.14 One Pot dialysis of 50 µM 5-carboxyfluorescein labeled Aβ starting at pH 11,
then dialyzing against 100 µM acetate buffer, pH 4, increasing concentrations of calcium
chloride, 0.1 N HCl and 50 mM phosphate buffer, pH 7.2.
The percent amplitude corresponding to each biexponential point plotted in Figure
5.14 is displayed in Figure 5.15. Since each point represent an average of triplicate runs,
the signal amplitude of each individual run was plotted. It appeared that the larger species
were dominant in solution and represented about 75% of the sample. This value
fluctuated slightly between 60% and 75% when the sample was dialyzed for a period of
time in acetate buffer. Since different regions within the sample were chosen for
measurement, the variation in the signal amplitude suggests that different species were
present. This variation may also indicate that perhaps some regions within the cell
experienced more perturbation from the pulsating action of the dialysis fluid circulating
through the subchamber. This experiment showed the potential of the in situ dialysis cell
to vary pH in small steps and also follow the changes from the addition of salt. If one

69

considers the variation of pH environments that proteins encounter within the cell, then
the in situ dialysis cell may be able to simulate such cellular environments to provide
information about the structural changes of a proteins’ passage through such changing
environments.
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Figure 5.15 Percent amplitude of fast and slow components of FPR diffusion coefficient
values in Figure 5.14.
The reversibility of Aβ aggregation through pH changes was studied by
alternating the pH within the dialysis cell. First, the effect of pH on the diffusion
coefficient of labeled Aβ, without addition of unlabeled material was monitored. Figure
5.16 shows the diffusion coefficient of 100 µM labeled Aβ initially dissolved in 10 mM
KOH alternately dialyzed against 50 mM PB, pH 2.7, and 50 mM PB, pH 7.2. Since the
system is dilute, the diffusion coefficient can be converted to a hydrodynamic radius
through Stokes’ law. The hydrodynamic radius of the peptide at pH 7.2 is about 1.5 nm,
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typical of monomeric Aβ peptide. At pH 2.7, the formation of protofibrils resulted in
decreased diffusion coefficient, corresponding to a hydrodynamic radius of about 90 nm.
The sample was then dialyzed back against the phosphate buffer at pH 7.2. The diffusion
coefficient rose to the starting value. After periodically measuring the diffusion
coefficient while the sample was being dialyzed, for about 15 hrs, there was no
significant change in the diffusion coefficient value. The sample was not dialyzed back
against low pH as the microscope cover glass broke. The same experiment was repeated
with an alternate sample that contained unlabeled Aβ peptide.
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Figure 5.16 Diffusion from in situ FPR of 50 µM 5-carboxyfluorescein-Aβ starting at pH
11, then alternately dialyzed between pH 2.7 and pH 7.4.
Figure 5.17 shows the time response of the diffusion coefficient of 100 µM 5carboxyfluorescein-Aβ (25% mixed with unlabeled 75% Aβ), starting at pH 11 and
alternately dialyzed against 50 mM phosphate buffer, pH 2.7 and 50 mM phosphate
buffer, pH 7.4. The trend in the diffusion coefficient was similar to that obtained for the
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labeled Aβ peptide in Figure 5.16. The diffusion coefficient was converted to
hydrodynamic radius and at pH 7.4 the Aβ had a hydrodynamic radius of about 1.5 nm.
At the lower pH, 2.7, the hydrodynamic radius was 85 nm at the first cycle and decreased
to 46 nm on the second. Additional studies were done to determine the aggregation limit
of the Aβ peptide through dialysis. When the Aβ peptide was extensively dialyzed for a
week at pH 7.4, the diffusion coefficient started and remained stabilized at the same value
(1.75 × 10-6 cm2s-1) representative of a monomeric Aβ peptide.
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Figure 5.17 Diffusion from in situ FPR of 100 µM 5-carboxyfluorescein-Aβ (25% mixed
with unlabeled 75% Aβ) starting at pH 11, then alternately dialyzed between pH 2.7 and
pH 7.4.
5.3.3 Interaction of Aβ Peptide with Peptide Mediators
•

Non-fibril forming Accelerators
The hydrophobic core, KLVFF, of the Aβ peptide has been used by several

researchers to design inhibitors of Aβ aggregation and dissolution of pre-formed fibrils.
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Peptides containing alpha-alpha disubstituted amino acids (ααAA) were designed and
prepared at LSU as potential inhibitors of Aβ fibril formation. The Murphy and Meredith
peptides (designed by Regina M. Murphy at University of Wisconsin and Stephen C.
Meredith at the University of Chicago, respectively) were also prepared at LSU and used
as control. FPR was used to identify mechanistic differences in how the different
mediator peptides interact with Aβ. Samples were prepared at a 1:1 ratio with 100 µM 5carboxy-fluorescein Aβ and mediator peptides in 50 mM PBS, 150 mM NaCl, pH 7.4. A
sample composed of 100 µM 5-carboxy-fluorescein Aβ and a mixture of 5-carboxyfluorescein Aβ with unlabeled Aβ peptide was also measured for comparison. Figure 5.18
shows the diffusion coefficient as a function of time for 5-carboxy-fluorescein Aβ and
mediator peptides: Amy1, Amy2, Modified Amy, Murphy, and Meredith. The diffusion
coefficient of all the Aβ and mediator peptide mixtures tended to decrease after fifteen
hours of sample preparation, with the exception of fluorescein-Aβ: Amy1 which seemed
to maintain a constant diffusion coefficient value for the duration of the experiment. The
sample mixture of 5-carboxy-fluorescein Aβ and unlabeled peptide had the fastest
diffusion coefficient values while the fluorescein Aβ: Modified Amy mixture had the
lowest diffusion coefficient value overall. These results are an early indication that the
mediator peptides all have different modes of interaction with the Aβ peptide. The results
mostly seem to indicate that the mode of inhibition may not involve shrinkage of the Aβ
peptide, as the decreasing trend in the diffusion coefficient values implies increasing
particle size. The diffusion coefficient results of the mixture of 5-carboxy-fluorescein Aβ
and unlabeled peptide is a bit perplexing as the 5-carboxy-fluorescein Aβ would have
been expected to have the fastest diffusion coefficients. Perhaps, the unlabeled peptide is
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causing the 5-carboxy-fluorescein Aβ to collapse on itself, becoming smaller as a result.
Another explanation might be that the unlabeled Aβ peptide repels the 5-carboxyfluorescein Aβ molecules, making them freer to move in solution. Whatever the scenario,
the diffusion coefficient results are indicative of small molecules with increased mobility.
The results from FPR studies on the interaction of Aβ with mediator peptides
indicated that the 5-carboxy-fluorescein labeled Aβ peptide could track changes in the Aβ
peptide aggregation kinetics in the presence of peptide-based mediators. Thus, the
question of whether the labeled Aβ peptide could be substituted for Thioflavin T (ThT) as
an alternate means of monitoring fibril growth or disassembly was addressed.
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Figure 5.18 Diffusion coefficients of Aβ and peptide-based mediators as a function of
time. Conditions: 100 µM 5-carboxy-fluorescein labeled Aβ and 100 µM 5-carboxyfluorescein labeled Aβ with 100 µM: Amy1, Amy2, Modified Amy, Murphy, and
Meredith in 50 mM PBS, 150 mM NaCl, pH 7.4.
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Thioflavin T is a fluorescence probe that exhibits enhanced fluorescent properties
upon binding to amyloid fibrils.147 Several studies have utilized ThT fluorescence for
monitoring Aβ kinetics.28;148;149 While ThT fluorescence is a highly sensitive probe for
detecting fibril formation, its earliest binding activity has been reported to commence
with the oligomeric form of the Aβ peptide.138;147 Perhaps, the 5-carboxy-fluorescein
labeled Aβ peptide would be able to detect even earlier stages of Aβ aggregation and
therefore eliminate the need for ThT. Ultimately, it could be used for screening the
efficacy of Aβ mediators. Fluorescence spectroscopy, using 5-carboxy-fluorescein
labeled Aβ as the probe, was used to monitor the kinetics of amyloid fibril formation and
the effect of peptide mediators on Aβ aggregation. FPR measurements were done on the
same samples for quantitative assessment of the data.
Initial fluorescence spectroscopy experiments were done with different
concentrations of the 5-carboxy-fluorescein labeled Aβ and mixtures with unlabeled
peptide to determine the optimal concentration whereby the sensitivity limit of the
detector would not be exceeded. Subsequently, a series of samples were prepared by
diluting appropriate concentrations of Aβ peptide and peptide-based mediator stock
solutions directly (to take advantage of its high-throughput capabilities) into a 96-well
plate for fluorescence spectroscopy measurements. Aliquots of the same samples were
loaded in 0.1-mm-path-length rectangular microslides (Vitrocom) by capillary action, and
the microslides were flame-sealed for FPR measurements.
The fluorescence spectroscopy results had no meaningful interpretation. A screen
capture of the results plotted in real time in an Excel spreadsheet by the FLUOstar
Galaxy software is shown in Appendix A. A table showing a 96-well plate layout with
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the corresponding sample identification is also shown in Appendix A. While the 96-well
plate is highly efficient for fluorescence spectroscopy, it proved a rather daunting task to
perform the FPR experiment with all the samples on the same day. Table 5.1 summarizes
the diffusion coefficient results for Aβ and Aβ in the presence of various peptide
mediators obtained by FPR. The LAβ samples are composed of 0.1 µM 5-carboxyfluorescein labeled Aβ and LAβAβ represent mixtures of 0.1 µM 5-carboxy-fluorescein
labeled Aβ and 25 µM unlabeled Aβ. The FPR results show that under physiological
conditions (50 mM PBS, 150 mM NaCl, pH 7.4, incubated at 37 °C for one day), all the
samples (Aβ and Aβ mixed with peptide-based mediators) had a diffusion coefficient
representative of a predominantly low oligomeric state (monomer-dimer in equilibrium)62
value, with the exception of LAβAβ-Amy1 and LAβAβ-Amy2. Both the labeled Aβ and
the mixture of labeled Aβ and unlabeled Aβ had diffusion coefficient values that were
similar within experimental error. In subsequent experiments a mixture of labeled Aβ and
unlabeled Aβ was chosen in an effort to limit the presence of the fluorophore and have a
more native-peptide-like sample. The additional diffusion coefficient value for the
LAβAβ-Amy1 peptide was only 3.5% of the single amplitude. This suggests that a very
small amount of higher order aggregates were present in the solution. The FPR
measurements of the LAβAβ-Amy2 sample gave diffusion coefficient values
representative of predominantly slowly diffusing molecules, corresponding to large
aggregates (observed visually at 18× magnification in the light microscope). The slowly
diffusing species represented about 80% of the signal amplitude. The data for two of the
three runs of the LAβAβ-Amy2 sample were biexponential and the third run fitted best
with a triple exponential analysis. The significant difference in the percentage of
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aggregates present in the LAβAβ-Amy1 and LAβAβ-Amy2 samples indicate that the
peptides interact with Aβ via different mechanisms. It was necessary to perform
additional measurements on fresh samples of LAβAβ-Amy1 and LAβAβ-Amy2 at
shorter time scales to determine how quickly those aggregates formed.
Several samples composed of different ratios of 5-carboxyfluorescein labeled Aβ,
unlabeled Aβ and Amy2 peptide were prepared to monitor the kinetics of Aβ and Amy2
mediator peptide assembly. Table 5.2 shows the summary of diffusion coefficient results
for Aβ and Aβ: Amy2 peptide mediator obtained by FPR.
Table 5.1 Summary of FPR diffusion coefficient results for 5-carboxy-fluorescein labeled
Aβ (LAβ) and peptide-based mediators. LAβAβ represents the code name for mixtures of
5-carboxy-fluorescein labeled Aβ and unlabeled Aβ. The error represents standard
deviation determined by triplicate measurements of the sample. a Only one of the
replicate runs fitted with a triple-exponential analysis. b The percent amplitude of the
single run with triple-exponential analysis.
Sample
(50 mM PBS, 150
mM NaCl, pH 7.4
– incubated at 37
°C for 1 day)
0.1 µM
LAβ
0.1:25 µM
LAβAβ
0.1:25:25 µM
LAβAβ-Murphy
0.1:25:25 µM
LAβAβ-Meredith
0.1:25:25 µM
LAβAβ-Modified
0.1:25:25 µM
LAβAβ-Amy1

Diffusion Coefficient (cm2s-1)
(% - Average Percent Amplitude of Signal)

(1.92 ± 0.193) × 10-6
100%
(2.15 ± 0.031) × 10-6
100%
(1.76 ± 0.0669) × 10-6
100%
(2.24 ± 0.0305) × 10-6
100%
(2.15 ± 0.170) × 10-6
100%
(1.46 ± 0.198) × 10-6

(Multiple Exponential Analysis)

(3.82 ± 1.22) × 10-9

96.5%

0.1:25:25 µM
LAβAβ-Amy2

3.5%
(2.45 ± 1.62) × 10-8

-7a

3.8 × 10

b

12%
8%

21%
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(1.94 ± 0.017) × 10-9
88%
71%

There was no significant difference in the diffusion coefficient values for different ratios
of Amy2 in the presence of 5-carboxy-fluorescein labeled Aβ. In the presence of almost
equal molar ratios of Aβ and Amy2 mediator, the data fitted best with triple exponential
analysis for all three runs.
The largest species represented about 60% of the signal amplitude, while each of
the remaining species represented about 20% of the signal amplitude. When the molar
ratio of the Amy2 peptide increased to 2:1 of Amy2: LAβAβ, only two exponentials were
observed with the slower diffuser dominant at 78%. The molar ratio of Amy2 peptide
was increased to 10:1 of Amy2: LAβAβ. At this ratio, only one diffusing species was
observed with a diffusion coefficient value representative of monomeric Aβ. The
interaction of Amy2 mediator with the Aβ peptide indicated that large aggregates were
formed almost immediately upon placing the mediator in the presence of Aβ. At the
highest molar ratio (10:1) of Amy2 to Aβ peptide, the characteristic formation of large
aggregates was absent, indicating that the excess mediator peptide may be blocking the
assembly of the Aβ peptide. A three dimensional, 3-D, representation of the distributions
of the various species present is a mixture of LAβAβ: Amy2 at a ratio of 0.1:25:25 µM is
shown in Figure 5.19. Immediately after preparing the samples, there were three species
in solution, the largest represented the broad peak and the smallest represented the small
peak. After one day of incubation at room temperature, the broad peak has become
bigger, while the small and middle peaks are now represented by one small peak. Three
days after sample preparation, only one broad peak is observed. The distribution trends
suggest that the initial amounts of monomeric and low oligomeric peptide got depleted to
compensate for the growth of the larger aggregates.
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Table 5.2 Summary of FPR diffusion coefficient results for 5-carboxy-fluorescein labeled
Aβ (LAβ) and Amy2. LAβAβ represents the code name for mixtures of 5-carboxyfluorescein labeled Aβ and unlabeled Aβ. The error represents standard deviation
determined by triplicate measurements of the sample.
Ratio Diffusion Coefficient (cm2s-1)
Sample
(50 mM PBS,
150 mM NaCl,
pH 7.4–
incubated at 37
°C for 1 day)
0.1:25 µM

(% - Average Percent Amplitude of Signal)

0.1:1

LAβ-Amy2
0.1:50 µM

0.1:2

LAβ-Amy2
0.1:25:25 µM

68%

(3.74 ± 0.938) × 10-8

(5.61 ± 0.353) × 10-9

27%

73%

20.7%

0.1:1:2 (1.72 ± 2.06) × 10-7

LAβAβ-Amy2

(3.65 ± 1.92) × 10-9

32%

0.1:1:1 (9.86 ± 1.57) × 10-8

LAβAβ-Amy2

0.1:25:50 µM

(2.72 ± 1.27) × 10-8

22%

(1.49 ± 0.380) × 10-8

(1.4 ± 0.033) × 10-9

17.83%

61.5%

(2.31 ± 0.437) × 10-9
78%

0.1:25:250 µM

0.1:1:1 (2.53 ± 0.153) × 10-6

LAβAβ-Amy2

0

100%

This clearly implies that Amy2 alters the rate of Aβ assembly by forming large
aggregates. Etienne et al.150 suggested that the Amy2 mediator peptide, (oligolysine on
the N-terminus) disrupts Aβ assembly only at the hydrophilic N-terminus of the Aβ
peptide. When the Amy2 mediator peptide was interacted with only labeled Aβ, which
has a 5-carboxy-fluorescein molecule attached to the N-terminus of the Aβ peptide, the
formation of large aggregates was still observed, similar to studies done with Amy2 and
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Aβ peptide without an attached fluorophore. This may be further validation to the claim
that the attachment of a fluorophore does not disrupt the normal structural activity of the
Aβ peptide or it may be an indication that the Amy2 peptide has alternate binding sites
other than the N-terminus of the Aβ peptide.
Similar FPR studies were done with the Amy1 mediator peptide in the presence of
a mixture of 5-carboxy-fluorescein labeled Aβ and unlabeled Aβ (LAβAβ). Table 5.3
summarizes the diffusion coefficient of the Amy1 mediator peptide in the presence of a
mixture of 5-carboxy-fluorescein labeled Aβ and unlabeled Aβ at different time periods.
The sample composition was 0.1 µM 5-carboxy-fluorescein labeled Aβ and a one to one
molar ratio of unlabeled peptide and Amy2 mediator peptide at 25 µM, in 50 mM PBS,
150 mM NaCl, pH 7.4.
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Figure 5.19 3-D representation of the diffusion coefficient data from LAβAβ: Amy2 at a
ratio of 0.1:25:25 µM.
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The diffusion coefficient result obtained at zero hours and eight hours were
almost identical within experimental error. After one day of incubation at 37 °C, the
presence of a small percentage (4%) of a larger species was observed. After three days,
the percentage of the larger species remained almost constant with a negligible 1%
increase in the signal amplitude on day 3.
Table 5.3 Summary of FPR diffusion coefficient results for Amy1 in the presence of 5carboxy-fluorescein labeled Aβ and unlabeled Aβ (LAβAβ). LAβAβ represents the code
name for mixtures of 5-carboxy-fluorescein labeled Aβ with unlabeled Aβ. The error
represents standard deviation determined by triplicate measurements of the sample.
Ratio Diffusion Coefficient (cm2s-1)
Sample
(50 mM PBS,
150 mM NaCl,
pH 7.4–
incubated at 37
°C for 1 day)
0.1:25:25 µM
LAβAβ-Amy1
0.1:25:25 µM
LAβAβ-Amy1
0.1:25:25 µM
LAβAβ-Amy1
0.1:25:25 µM
LAβAβ-Amy1
0.1:25:25 µM
LAβAβ-Amy1

(% - Average Percent Amplitude of
Signal)
0.1:1:1 (2.05 ± 0.185) × 10-6
100%
0hrs
0.1:1:1 (2.24 ± 0.046) × 10-6
100%
8hrs
0.1:1:1 (1.46 ± 0.198) × 10-6
96%
1 day

(3.82 ± 1.22) × 10-9
4%

0.1:1:1 (1.61 ± 0.101) × 10-6
96%
2 days

(1.01 ± 0.342) × 10-8
4%

0.1:1:1 (1.66 ± 0.014) × 10-6
95%
3 days

(1.82 ± 0.225) × 10-8
5%

Figure 5.20 shows a graphical representation of the diffusion coefficient values found in
Table 5.3. The fast diffusers are clearly dominant throughout the experimental time
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frame. Although the percentages of the larger diffusers are consistently low, the general
trend in the diffusion coefficient values indicates that the sizes of these species are getting
smaller with time. This suggests that the Amy1 mediator is disrupting the assembly of the
Aβ to create smaller particles.
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Figure 5.20 Diffusion coefficients as a function of time for Amy1 in the presence of 5carboxy-fluorescein labeled Aβ and unlabeled Aβ (LAβAβ). Conditions: 0.1 µM labeled
Aβ and a 1:1 molar ratio of unlabeled Aβ and Amy1 at 25 µM in 50 mM PBS, 150 mM
NaCl, pH 7.4.
FPR studies were performed with all the mediator peptides (Amy1, Amy2,
Modified Amy, Murphy, Meredith) including the addition of another potential mediator
molecule, one-directional [9]-6 arborol. One-directional arborols ([9]-n) are amphiphilic,
tree shaped dendrimers with nine hydroxyl groups ([9]-) forming the hydrophilic head
and an alkyl chain as the hydrophobic moiety (n stands for the number of carbons in the
alkyl chain; in this case, n = 6).151-153 Sun154 discovered that the arborol molecules
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exhibited almost similar fibrillar self-assembly properties to the Aβ peptide. Could the
shorter, one-directional [9]-6 arborol molecule interact with the Aβ peptide to inhibit the
amyloid fibril assembly? The amphiphilic nature of the one-directional [9]-6 arborol, plus
the fact that is has a much smaller molecular weight than most of the designed and costly
peptide-based amyloid inhibitors are some desirable properties that makes this potential
amyloid fibril mediator worth investigating. The structure of the one-directional 9-6
arborol is shown in Figure 5.21.
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Figure 5.21 Structure of one-directional [9]-6 arborol.
The diffusion coefficient values as a function of time for each mediator and Aβ
peptide combinations are shown. For the purpose of clarity, the data is presented as
individual plots for each sample. Figure 5.22 shows the diffusion behavior of 10 µM 5carboxy-fluorescein Aβ as a function of time. For a period of one week the diffusion
coefficient remained at an almost constant value with a slight decrease at days 5 and 7.
The diffusion coefficient was representative of values for monomeric Aβ (refer also to

83

Figure 5.5). Figure 5.23 shows the diffusion behavior of 10 µM 5-carboxy-fluorescein Aβ
mixed with 25 µM unlabeled Aβ as a function of time. For the first three days the
diffusion coefficient remained at an almost constant value, characteristic of the ‘lag
phase’ that precedes fibril growth. At days 5 and 7, the presence of larger aggregates was
observed.
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Figure 5.22 Diffusion coefficients as a function of time for 5-carboxy-fluorescein Aβ (5CF-Aβ). Conditions: 10 µM 5-carboxy-fluorescein Aβ was prepared in 50 mM PBS, 150
mM NaCl, pH 7.4.
Initially, the larger species represented only 2 % of the signal amplitude, but by
the seventh day, that value had increased dramatically to 32%. This demonstrates the
‘seeding’ effect of the Aβ. The presence of small amounts of seeds was sufficient to
initiate Aβ peptide assembly.
Figure 5.24 shows the diffusion behavior of 10 µM 5-carboxy-fluorescein Aβ and
a one-to-one molar ratio of unlabeled peptide and Amy1 mediator peptide at 25 µM, in 50
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mM PBS, 150 mM NaCl, pH 7.4. Initially, only a single diffusion coefficient is observed.
Measurements on subsequent days indicated that larger species were present in solution.
The large difference in the diffusion coefficient from the first day of sample measurement
suggests that the Amy1 peptide is most likely inducing the aggregation state of the
peptide as results for the control peptide indicated that only small species were present in
solution up to about the fifth day of measurement. The large differences (randomness) in
the percent signal amplitudes simply reflect the heterogenous nature of the sample. As
different regions of the sample are selected for photobleaching during FPR measurement,
this implies that the aggregates are not uniformly distributed within the sample cell.
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Figure 5.23 Diffusion coefficients as a function of time for 5-carboxy-fluorescein Aβ (5CF-Aβ) mixed with unlabeled Aβ. Conditions: 10 µM 5-carboxy-fluorescein Aβ mixed
with 25 µM unlabeled Aβ prepared in 50 mM PBS, 150 mM NaCl, pH 7.4.
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Figure 5.25 shows the diffusion behavior of 10 µM 5-carboxy-fluorescein Aβ and a oneto-one molar ratio of unlabeled peptide and Amy2 mediator peptide at 25 µM, in 50 mM
PBS, 150 mM NaCl, pH 7.4. In contrast to Amy1 and the control samples, large
aggregates were observed immediately after sample preparation. This is reflected in the
range of diffusion values shown in Figure 5.25. There was no time dependence on the
aggregation behavior of the Amy2 peptide with Aβ as the lowest diffusion values seem to
be stabilized around (3.51 ± 1.8) × 10-10 cm2s-1.
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Figure 5.24 Diffusion coefficients as a function of time for 5-carboxy-fluorescein Aβ (5CF-Aβ) mixed with unlabeled Aβ and Amy1. Conditions: 10 µM 5-carboxy-fluorescein
Aβ mixed with 1:1 molar ratio of unlabeled Aβ and Amy1 at 25 µM, prepared in 50 mM
PBS, 150 mM NaCl, pH 7.4.
Figure 5.26 shows the diffusion behavior of 10 µM 5-carboxy-fluorescein Aβ and
a one-to-one molar ratio of unlabeled peptide and Modified Amy mediator peptide at 25
µM, in 50 mM PBS, 150 mM NaCl, pH 7.4. The trend in the diffusion coefficient results
appears identical to that of the control peptide in Figure 5.23. The only difference is in
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the percent signal amplitude on day 7, where the Modified Amy peptide has a higher
percentage of large diffusers than the control Aβ peptide. This suggests that the Modified
Amy mediator peptide has a cat and mouse approach to mediating Aβ peptide
aggregation.
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Figure 5.25 Diffusion coefficients as a function of time for 5-carboxy-fluorescein Aβ (5CF-Aβ) mixed with unlabeled Aβ and Amy2. Conditions: 10 µM 5-carboxy-fluorescein
Aβ mixed with 1:1 molar ratio of unlabeled Aβ and Amy2 at 25 µM, prepared in 50 mM
PBS, 150 mM NaCl, pH 7.4.
Both peptides co-exist in solution with the Modified Amy being the watch(cat) of the Aβ
peptide activity. It appears that as soon as any Aβ aggregation begins, the Modified Amy
works to destroy those aggregates most likely by binding to Aβ. The Murphy and
Meredith peptides, Figure 5.27 and 5.28 respectively, both seem to utilize similar
mechanisms for mediating Aβ peptide assembly.
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Figure 5.26 Diffusion coefficients as a function of time for 5-carboxy-fluorescein Aβ (5CF-Aβ) mixed with unlabeled Aβ and Modified Amy. Conditions: 10 µM 5-carboxyfluorescein Aβ mixed with 1:1 molar ratio of unlabeled Aβ and Modified Amy at 25 µM,
prepared in 50 mM PBS, 150 mM NaCl, pH 7.4.
Figure 5.29 top, shows the diffusion behavior of 10 µM 5-carboxy-fluorescein Aβ
and a one to one molar ratio of unlabeled peptide and the one-directional [9]-6 arborol
molecule at 25 µM, in 50 mM PBS, 150 mM NaCl, pH 7.4. The trend in the diffusion
results seems to mimic that of Amy2 with the exception that no large diffusers were
observed on day 1. The one-directional [9]-6 arborol has been found to be very surface
active molecules.155 Transmission electron microscopy (TEM) of Aβ in the presence of
one-directional [9]-6 arborol revealed the presence of large micellar-type structures
similar to results obtained for one-directional [9]-6 arborol alone at concentrations
exceeding its critical micelle concentration (CMC). It appears that the one-directional [9]6 arborol is behaving like a cosurfactant to stabilize the Aβ aggregation.
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Figure 5.27 Diffusion coefficients as a function of time for 5-carboxy-fluorescein Aβ (5CF-Aβ) mixed with unlabeled Aβ and Murphy. Conditions: 10 µM 5-carboxy-fluorescein
Aβ mixed with 1:1 molar ratio of unlabeled Aβ and Murphy at 25 µM, prepared in 50
mM PBS, 150 mM NaCl, pH 7.4.
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Figure 5.28 Diffusion coefficients as a function of time for 5-carboxy-fluorescein Aβ (5CF-Aβ) mixed with unlabeled Aβ and Meredith. Conditions: 10 µM 5-carboxyfluorescein Aβ mixed with 1:1 molar ratio of unlabeled Aβ and Meredith at 25 µM,
prepared in 50 mM PBS, 150 mM NaCl, pH 7.4.
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To get a better idea of the nature of the species that formed in solution, an aliquot
of the sample was examined by TEM. Figure 5.29, middle and bottom, shows TEM
images of the 10 µM 5-carboxy-fluorescein Aβ and a one to one molar ratio of unlabeled
peptide and the one-directional [9]-6 arborol molecule at 25 µM, in 50 mM PBS, 150
mM NaCl, pH 7.4 negatively stained with 2% uranyl acetate. The top image was taken at
a magnification of 50KX and the bottom image was taken at a magnification of 100 KX.
The small, spherical-type lighter areas in the images are characteristic of the aggregation
behavior of the arborol molecule.152 Although the top image appeared to have some
‘barely’ visible fibrillar-mesh in the background, closer examination of the sample at
higher magnification did not reveal the obvious presence of fibrils.
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Figure 5.29 Top: Diffusion coefficients as a function of time for 5-carboxy-fluorescein
Aβ (5-CF-Aβ) mixed with unlabeled Aβ and one-directional 9-6 arborol. Conditions: 10
µM 5-carboxy-fluorescein Aβ mixed with 1:1 molar ratio of unlabeled Aβ and Amy1 at
25 µM, prepared in 50 mM PBS, 150 mM NaCl pH 7.4.
(figure continued)
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Figure 5.29 (continued) Middle and Bottom: TEM images of the 5-carboxy-fluorescein
Aβ (5-CF-Aβ) mixed with unlabeled Aβ and one-directional 9-6 arborol negatively
stained with 2% Uranyl acetate. Middle image was taken at a magnification of 50KX and
the Bottom image was taken at a magnification of 100 KX.
A dynamic light scattering experiment was used to follow the behavior of the
mediator peptides in the presence of Aβ. Figure 5.30 shows a simple DLS experiment
designed to assess the the behavior of the Murphy peptide against large Aβ fibrils. After
disrupting the large and slowly growing fibrils by sonication, the system remains stable
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for hours. This suggests that aged, broken fibrils are not easily healed. Addition of the
Murphy peptide rapidly accelerates fibril growth. This experiment is effective for
screening mediator peptides and can help guide the synthesis of new materials.

Addition of 5µL of 500µM
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Figure 5.30 Growth kinetics of β-amyloid at physiological pH. β-amyloid was dissolved
in neat DMSO at a concentration of 1 mg/mL followed by dilution in 50 mM PBS, 150
mM NaCl, pH 7.4, yielding a concentration of 100 µM. The apparent hydrodynamic
radius was determined from cumulant analysis of dynamic light scattering data taken at
90° scattering angle.
Figure 5.31 shows the dynamic light scattering results for Aβ in the presence of
Amy1 and Amy2 mediator peptides at two different ratios (1:1 and 1:5). The
hydrodynamic radius of the Aβ is greatly accelerated in the presence of Amy2. In
contrast, in the presence of the Amy1 peptide, the Aβ is only slightly larger than the
control.
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Figure 5.31 Dynamic light scattering results of Aβ and its interaction with peptide-based
inhibitors. The hydrodynamic radius if plotted as a function of time.
5.4 Conclusions
Fluorescence photobleaching recovery (FPR) studies on 5-carboxyfluorescein
labeled β-amyloid peptide solutions readily confirmed the coexistence of large and small
species. This routine experiment can effectively screen inhibitors and can guide the
synthetic enterprise.

To address the question of reversibility, and to improve the

economy of experimenting with expensive Aβ peptide and inhibitors, in situ dialysis cells
for DLS and FPR were developed. The reversibility of the peptide conformation from
the low oligomeric state to the aggregated state under neutral and acidic pH conditions
and confirmed that the peptide growth increased with increasing ionic strength.
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CHAPTER 6
INTERACTION BETWEEN β-AMYLOID PEPTIDE AND LIPID BILAYERS
6.1 Introduction
The earliest experimental studies to predict that lipid molecules in membranes
were organized bilayers were done by E. Gorter and F. Grendel in 1925.156 Later, studies
performed with instrumental techniques such as X-ray diffraction, freeze-fracture
electron microscopy and X-ray crystallography helped confirm that the lipid bilayer
provides the basic structure of biological membranes. These experiments provided vital
evidence to support the fluid mosaic model of membrane structure proposed by S. J.
Singer and G. L. Nicolson in 1972.157 Although the Singer model appears simple in view
of the considerable progress that has been made in unraveling the complexity of
biological membranes, it remains a useful starting point for comprehending cellular
membrane structure.
The major constituent of all biological membranes is lipid molecules (30 – 80%),
proteins (20 – 60%) and carbohydrates (0 – 10%). The lipid bilayer has a typical
membrane thickness of 4-5 nm and has been described as a fluid matrix, within which
protein molecules are attached, adsorbed, inserted or embedded. Among the major types
of lipids present in the cell membrane, the phospholipids are the most common, followed
by cholesterol and glycolipids. The structure, composition and interaction of a lipid
bilayer with membrane proteins determine its function. An important property of a lipid
layer which is crucial to many of its function is its fluidity. The degree of fluidity may
vary from being highly fluid to a partially fluid state depending on the arrangement and
composition of membrane components. For example, cholesterol molecules are important
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in maintaining the flexibility and stability of the cell membrane, but affect the lipid
bilayer by decreasing its fluidity. Cell membranes must be in a relatively fluid state to
maintain their normal biological function. Thus, it is necessary to understand the structure
and dynamic properties of lipid molecules within the membrane environment, combined
with their interaction with proteins as this may provide insight into the orientation and
structural transformation that occurs upon insertion of proteins into lipid membranes.158
The discovery of liposomes (small artificial lipid vesicles) by A. Bangham in
1962159 provided a suitable model system that closely mimicked natural cell membranes
to study such fundamental processes.160;161 Several unique properties make vesicles ideal
artificial membrane mimics.162;163 One advantage of lipid vesicles is their ability to form
spontaneously in aqueous environments and self-assemble into structures such as
monolayers or bilayers on solid supports (glass, quartz, mica, silicon chips).158;164-168
Additional properties such as permeability to ions, and versatility (it is possible to vary
and control composition, pH, and ionic strength) have made it possible to study a variety
of physical parameters of these systems. For instance, tremendous effort is being applied
to the study of the interactions and binding properties of various proteins and other
molecules to lipid membrane surfaces. Extensive documentation exists on the potential
uses of liposomes in a range of biological applications.169-171
Although scientists continue to gain deeper understanding of lipid vesicles and
have, in some cases, been able to correlate these fundamental properties with those of
natural membranes, major areas of research remain to be explored.172 Tremendous effort
is being directed towards development of biophysical techniques, and progress is being
made in the areas of pathogen attack,173 inflammatory response, design of more realistic
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and sophisticated model membrane systems (tethered polymer-supported lipid bilayer
artificial membranes),174-176 and membrane pathologies that result in cellular
dysfunction.177
The objective of this work is to develop model membrane systems to study the
interaction between β-amyloid peptide (Aβ) and lipid bilayers and understand how the
lipid membrane affects the properties of Aβ (and vice versa). Specifically, the effect the
Aβ peptide attribute to the fluidity of the lipid membrane will be addressed. The results
from several studies are misleading as some indicate that Aβ alters the membrane by
increasing its fluidity while others report the opposite effect. The reader is directed to a
review article by Wood et al.,178 for a summary of the studies dealing with the effects of
Aβ on membrane fluidity both in model and biological membranes. The experimental
results are clearly controversial and further investigations with suitable model systems
and biophysical techniques are needed.
6.2 Interaction of β-amyloid with Lipid Bilayers
Many researchers have investigated the interaction of Aβ with natural179-182 and
artificial (brief review follows) lipid membranes. Based on its amphiphilic nature, Aβ can
interact with membranes resulting in several membrane perturbing effects, which may
play a pivotal role in the pathogenic casade leading to Alzheimer’s disease. It remains a
difficult task to pinpoint the exact mechanism via which Aβ becomes toxic to cells.
Nevertheless, it is evident that the concentration of Aβ found in cerebrovasular fluids in
vivo is insufficient to initiate fibril growth in vitro. Thus, it is possible that the toxicity of
Aβ to cells may result from a direct consequence of specific interactions upon binding to
the membrane surface. In fact, several researchers have found evidence that the Aβ
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changes conformation from a random coil to β-sheet upon binding the membrane. The βsheet structure adopted by the Aβ peptide is crucial for formation of fibrils; thus, if
indeed interaction with the membrane surface initiates fibril formation, then this may
account for the low concentrations of the peptide found in vivo.
Terzi et al.183 demonstrated that the binding of monomeric Aβ25-35 peptide to
negative lipid vesicles is possible primarily through electrostatic interactions. Subsequent
studies with the Aβ1-40 peptide by Terzi et al.184;185 and later, Bokvist et al.186 revealed
that a conformational change from random coil to β-sheet structure occurs when the
peptide binds negatively charged, small unilamellar lipid vesicles (SUV) (under
conditions of low ionic strength; about 5 -10 mM MOPS or Tris buffer, without NaCl);
neutral membranes had no effect on the monomeric form of the peptide. Terzi et al.185
failed to observe a conformational change at physiological ionic strength. Studies by
McLaurin et al.187 also confirmed that negatively charged membranes can induce a
conformational change from random coil to β-sheet in the Aβ1-40 peptide in the presence
of SUVs but only under conditions of lowered pH values.
In alternate studies, Choo-Smith et al.188 varied the membrane system to include
ganglioside as it was believed that the ‘lipid rafts’ are the preferential site for the
formation of the Aβ fibrils. Several other studies have confirmed the accelerated
formation of Aβ fibrils in the presence of membranes composed of sphingomyelin and
cholesterol.189-192 Other effects that have been reported to result from the interaction of
the Aβ peptide with membranes include: formation of Ca2+ channels and ion pores193-195.
Despite the limitations of these studies, it is plausible that interaction of the Aβ peptide
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induces changes (subtle or otherwise) in the membrane environment which may be
deleterious to the cells.
6.3 Measuring Diffusion with FPR
To study the effect of Aβ on lipid membranes a combination of fluorescence
photobleaching recovery (FPR) and fluorescence microscopy was used. The detailed
technical information of FPR is presented in Chapter 4. Hence, a brief summary of the
suitability of this technique will be given. Many of the physiological functions of the cell
membrane depend on its mobility: transport of nutrients and waste into and out of the
cell, membrane fusion and cell interaction, responding to signals in the cellular
environment. The classic experiment by L. Frye and M. Edidin in the 1970s demonstrated
that membrane proteins diffuse freely in the lipid bilayer, implying that they were
fluid.196 Frye et al.196 labeled antigens at the surface of mouse and human cells with green
and red fluorescent dyes respectively. The cells were fused with Sendai virus to form
heterokaryons with both mouse and human surface antigens localized within specific
regions of the ‘newly-formed’ cells. The cells were incubated and later observed with a
microscope. While initially the red and green dyes were separated, through diffusion, the
molecules were found randomly distributed over the entire cell surface.
One great advantage of FPR is the fact that it was developed (and has been
successfully used) for studying the diffusion of molecules in biological systems,
including proteins and lipid within membranes.61;93;95-97;197-199 Fundamentally, the FPR
technique was designed with a similar concept to the experiment of Frye et al. Briefly, a
small spot in a fluorescently labeled sample is photobleached and the region is monitored
to detect the return of fluorescence as bleached and unbleached molecules randomize
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their positions through translational diffusion.200 Thus, FPR has been established as an
ideal technique for measuring mobility of molecules within membranes and should prove
effective for obtaining information on the nature of membrane fluidity upon interaction
with the Aβ peptide.
6.4 Interaction of Melittin with Lipid Bilayers
Melittin, the major toxic component of the venom of the honey bee, Apis
mellifera, is among the best-studied amphipathic α-helical polypeptides.201;202 Its 26amino-acid-sequence is arranged such that the amino-terminal part (residues 1-20) is
predominantly hydrophobic, whereas the carboxy terminal region (residues 21-26) is
hydrophilic and strongly basic, due to four positively charged (Lys-Arg-Lys-Arg) amino
acid residues.203;204 As a consequence of its structure, melittin binds natural, as well as
negatively charged and zwitterionic, phospholipid artificial membranes resulting in
different but profound effects in each case.205 Studies have reported that melittin forms
transmembrane pores via a “barrel-stave” mechanism in zwitterionic lipid bilayers, while
it acts like a detergent, (solubilizing membranes) via a “carpet-like” mechanism in
negatively charged membranes.206-209 Melittin has also been found to induce the fusion
of both small and large zwitterionic and acidic vesicles resulting in large structures.210-213
Although characterization of the various effects of melittin on membranes is not
complete, it has been a convenient model in providing insight into complex membrane
protein interactions.
Several of the characteristics of melittin were found to be similar to the properties
of the Aβ peptide; thus, melittin was chosen as a useful reference for comparison of the
lipid-peptide interactions in lipid bilayers. A few striking parallels between the two
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peptides are: their ability to change conformation upon binding to membrane, resulting in
changes in the membrane morphology; their ability to exert their toxic effects upon
interaction with membranes; and, their ability to form defects in membrane structure,
such as pores and channels. In this study, the interaction of melittin with vesicles and
lipid bilayers on mica was examined with fluorescence photobleaching recovery and
fluorescence microscopy.
6.5 Materials
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Figure 6.1. Chemical structures of the phospholipids POPC and the fluorescent probe
NBD-PC used in this study.
For this study all lipids used, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) in chloroform, and 1-oleoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4yl)amino]dodecanoyl]-sn-glycero-3-phosphocholine (NBD-PC) in chloroform, were
purchased from Avanti Polar Lipids, Inc. Chloroform (99.9% HPLC grade) was
purchased from Aldrich Chemicals. Melittin was purchased from Sigma. β-amyloid
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peptide was purchased from Anaspec, Inc. Imaging chamber (20 mm diameter, 1 mm
deep was purchased from Sigma-Aldrich. All fluorescent-probe-containing solutions
were wrapped in aluminum foil and stored in the dark to prevent photobleaching from
room light. Nanopure water for all experiments was obtained by a Barnstead Nanopure
Water System (18 MΩ cm) resistivity.
6.6 Preparation of Lipid Vesicles
The preparation of lipid vesicles of the right size and structure involves three basic
steps: first, prepare the lipid for hydration by first drying off organic solvents from the
lipid, resulting in a film; second, hydrate the lipid film in aqueous media; third, downsize
the formed hydrated lipid vesicles by sonication or extrusion.214 In this study, the lipids
POPC (1.9 mg) and NBD-PC (0.1 mg) were both dissolved in chloroform at the
concentration of 2 mg lipid/ mL of chloroform in a Pyrex test tube (13 × 100 mm) to
ensure a homogeneous mixture of lipids. Additional chloroform (1-2 mL) was added and
thoroughly mixed to ensure optimal film formation. The chloroform was subsequently
removed by rotatory evaporation (Buchler Instruments) for about 20 minutes, yielding a
thin lipid film in a round bottom flask. Residual chloroform was removed by placing the
flask in a vacuum oven overnight. The dried lipid film was hydrated with a 2-mL aliquot
of a 50 mM phosphate-buffered saline buffer, 150 mM NaCl at pH 7.4 and placed on a
rotatory evaporator without a vacuum – spinning the round bottom flask in a water bath
to maintain a temperature above the Tm of the lipid suspension for about one hour.
The resulting hydrated large, multilamellar vesicles (MLVs) were disrupted by
either sonication or extrusion to form small, unilamellar vesicles. Initally, the lipid
solution was sonicated with a micro tip Branson Sonifier 450 on an on-off cycle for five
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minutes total. The sonication tip was found to release titanium particles into the lipid
suspension, which need to be removed by centrifugation. In other cases, the sample was
often heterogeneous between batches. It was difficult to control and reproduce the
conditions of sonication, thus an alternate method was used.
The disruption of the MLV suspension was achieved by using the lipid extrusion
technique. Prior to disruption, the MLVs were alternately frozen in liquid nitrogen and
thawed in hot water (60 °C) for five freeze-thaw cycles to improve homogeneity of the
final lipid suspension. The MLVs were then extruded for 20 complete cyles through an
Avestin polycarbonate filter (100 nm pore size) on a liposofast-basic manual extrusion
apparatus. The diameter of the vesicles was measured by dynamic light scattering and a
value of 100-120 nm was found (near the pore size of the filter used). All vesicles in this
study were prepared by the extrusion technique because this method proved more
reproducible than sonified lipid vesicles.
6.7 Formation of Lipid Bilayers
Lipid bilayers have a natural tendency to form spontaneously215 (i.e. ∆G < 0), by
fusion or adsorption into a continuous bilayer membrane on several materials.216 The
formation of a lipid bilayer by vesicle adsorption on a hydrophilic surface involves three
steps: adsorption, rupture and spreading.217 The adsorption of lipids onto hydrophilic
surfaces is spontaneous due to the presence of the hydrophilic phosphate headgroups at
the outer surface of the vesicles. The electrostatic environment with fixed charges due to
the phosphate and choline groups218 causes the vesicles to flatten out onto the surface,
after which the vesicles are ruptured. Spontaneous spreading is facilitated by the presence
of a thin (1-2 nm) film of water216;219-222 (‘precusor film’) located between the vesicles
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and the hydrophilic surface. Strong self-assembly forces causes phospholipid membranes
of almost constant thickness to form as the membrane is very thin and close to the
hydrophilic surface.223 A schematic representation for vesicle interactions with
hydrophilic surfaces commonly presented in the literature is shown in Figure 6.2.

Figure 6.2. Schematic representation of vesicle fusion on a hydrophilic surface. Adapted
from reference 221.
The supported lipid bilayers were formed by pipetting a drop of the vesicle
solution (lipid concentration of 2 mg/mL) onto a freshly cleaved mica disk (10 mm)
which had been glued onto a mica puck and placed on a microscope slide. The sample
was allowed to incubate at room temperature for one hour in a covered Petri dish that had
been layered with a moist filter paper. After the incubation period, the sample was rinsed
with phosphate buffer to remove any unfused vesicles and a small volume of the buffer
was kept on the membrane at all times to prevent interference with the liquid-air
interface. The sample was then sealed with an imaging chamber to prevent air flow that
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could cause the liquid interface to move and also to prevent evaporation of the buffer
which would result in drying of the sample.224 For FPR studies involving the lipid
vesicles in solution, the samples were loaded in 0.2-mm-path-length rectangular
microslides (Vitrocom) by capillary action, and the microslides were flame-sealed.
6.8 Results
6.8.1 Fluorescence Imaging and FPR Analysis of Supported Lipid Bilayers
To obtain information on the structural and dynamic properties of supported
phospholipid bilayer on mica, fluorescence microscopy and fluorescence photobleaching
recovery (FPR) techniques were used. Representative fluorescence microscopy images
for mixed POPC/NBD-PC bilayers formed by direct vesicle fusion on mica observed at
different time points during experimentation are shown in Figure 6.3. It should be noted
that images such as those appearing in Figure 6.3 a-c were rarely observed, but the
patterns evidenced therein are recognized as important steps in the formation of defectfree supported membranes. The appearance of mobile unruptured spherical vesicles can
be seen in Figure 6.3a. This may be attributed to residual unfused vesicles that were not
completely rinsed away during sample preparation. Some defects can be observed in
Figure 6.3b due to incompletely formed membrane. Due to the mobility of the lipid
membrane, complete coverage of the surface is possible with additional time. The image
in Figure 6.3c was taken near the edge of the mica supported bilayer. A portion of the
lipid bilayer has holes and is separated by a portion that is defect free. It is not known
what caused the holes, but one can speculate that some tension, perhaps at the air-water
interface may have contributed to its formation. These holes can be likened to similar
‘circular defects’ observed in cholesterol containing planar ‘raft’ model membranes.219
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a)

b)

c)

d)

Figure 6.3. Fluorescence microscopy images of supported phospholipid bilayers on mica.
(a) spherical unfused vesicles floating on the membrane, (b) incompletely formed
membrane with defects, (c) holes within the lipid bilayer (d) uniform supported lipid
bilayer on mica. (Images were false colored with Adobe Photoshop).
Crane et al.219 reasoned that the circular defects in their fluorescence microscopy images
were possibly due to surface defects in the solid support or stretching during deposition
of the first lipid layer by the direction of the Langmuir-Blodgett. The uniformly (within
optical resolution) continuous supported membrane shown in Figure 6.3d was typically
used for experimentation.
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There are several methods to test the integrity of supported membranes formed by
vesicle fusion. While fluorescence microscopy can be used to obtain structural
information, it would not be an appropriate choice to determine the fluidity of a defectfree bilayer that is uniformly fluorescent. If the membrane is scratched, however, then it
should be possible to observe the fluidity of the membrane by its ability to spread into the
scratched region. In Figure 6.4a, the mica was mechanically scratched with a razor blade
prior to deposition of the vesicles onto its surface. The observed scratch was not ‘healed’
following incubation for one day, suggesting that spreading was unfavorable.164 Groves
et al.216 demonstrated that under neutral or basic conditions, scratch barriers are very
stable, whereas they heal in minutes under mildly acidic conditions. The scratch-free
regions within the bilayer were found to be ‘fluid’ by measurement of diffusion
coefficient with FPR. The stability of the scratch in the bilayer can be viewed as an
example of a barrier to lateral diffusion, in keeping with the natural ability of cell
membranes to restrict access to unwanted components. A stripe pattern photobleached
into a lipid bilayer is shown in Figure 6.4b.
FPR is an established technique for measuring lateral mobility and hence
determining the fluidity of lipid membranes.175 Supported membranes have been
demonstrated to exhibit many features of natural membranes including lateral fluidity. To
determine whether the prepared lipid membrane maintained its dynamic properties on the
mica support, its lateral diffusion was measured by FPR. The diffusion coefficient of both
NBD-PC/POPC vesicles and lipid bilayer on mica support was assessed by this method.
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a)

b)

Figure 6.4. Fluorescence microscopy images of supported phospholipid bilayers on mica.
(a) lipid bilayer which has been scratched (b) image of stripe pattern bleached into the
supported lipid bilayer, acquired with a 10× objective. The black spot is due to
photobleaching during a previous exposure at 63×, final objective 10× magnification.
(Image 6.4a was false colored with Adobe Photoshop).
The diffusion coefficient of the NBD-PC/POPC vesicles was determined to be (4.93 ±
0.27) × 10-8 cm2s-1 (Figure 6.5a). A typical FPR recovery profile appears in Figure 6.5a.
The inset shows a plot of Γ vs K2 whose slope provides the diffusion coefficient. The zero
intercept, within experimental error, indicates true Brownian diffusion rather than
relaxation due to convection or reversible photobleaching.225 A semilogarithmic FPR
trace of the data points in Figure 6.5a displays almost single exponential behavior,
indicating that the lipid vesicles were uniformly composed (Figure 6.5b).
After fusion of the NBD-PC/POPC vesicles with the mica surface to form a lipid
bilayer as in Figure 6.3d, the NBD-PC was observed to have a diffusion coefficient of
(5.99 ± 0.55) × 10-8 cm2s-1 (Figure 6.6a). The semilogarithmic plot also displays almost
single exponential behavior similar to the lipid vesicles (Figure 6.6b).
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Figure 6.5. Diffusion measurement of phospholipid vesicles in suspension. (a) Recovery
profile for NPD-PC/POPC (5:95 molar ratio) phospholipid vesicles. Inset: Γ vs K2 plot of
the same sample. (b) Semilogarithmic FPR trace of the data points in Figure 6.5a.
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Figure 6.6. Diffusion measurement of NBD-PC in a phospholipid bilayer. (a) Recovery
profile for NPD-PC/POPC (5:95 molar ratio) phospholipid bilayer on mica support. Inset:
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Figure 6.6a.
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The diffusion coefficient values obtained for NBD-PC probe lipid in both mica
supported bilayers and vesicles composed of NBD-PC/POPC (5/95 mol/mol) suggests
that membranes diffuse. The measured diffusion coefficients were also in the range (1-8
× 10-8 cm2s-1)94;165;226 reported for diffusion of phospholipid molecules in fluid
bilayers.222;227;228 After obtaining the diffusion coefficient of the lipid vesicles and
bilayers, it was determined that the membrane was sufficiently fluid and within the
expected values in literature. Thus, similar experiments were performed to determine the
interaction of the β-amyloid peptide and, later, melittin with lipid vesicles and lipid
bilayers.
6.8.2 Fluorescence Imaging and FPR analysis of the Interaction of β-amyloid with
Lipid Bilayers
Most studies have used fluorescence anisotropy to determine how Aβ affects the
fluidity of lipid membrane. As discussed earlier, discrepancies exist as to whether the Aβ
peptide increases or decreases the fluidity of the membrane. To address how Aβ alters
membrane fluidity, FPR was used to determine the diffusion of a fluorescent lipid probe,
1-Oleoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-sn-Glycero-3Phosphocholine (NBD-PC) on a mica-supported model membrane system made of 5%
NBD-PC and 95% 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) as the
major component. Figure 6.7 shows the trend of the surface diffusion of NBD-PC in a
bilayer with POPC as a function of time. The bilayer was incubated with pre-formed Aβ
protofibrils, followed by rinsing with buffer to remove any unbound material - the buffer
was used to keep the bilayer moist throughout the experiment. The data implies that the
fluidity of the lipid is compromised by the presence of fibrils, as indicated by the
decreasing diffusion results with time.
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Figure 6.7. Diffusion of 5% NBD-Labeled PC fluorescent tracer molecule in 95%
unlabeled POPC on mica with preformed β-amyloid1-40 fibrils.
To further explore the interaction of Aβ with lipid bilayer model membranes,
lipid bilayers were prepared as described previously and an aliquot of a 50 µM unlabeled
Aβ sample prepared in 50 mM PBS, 150 mM NaCl, pH 7.4 was applied to the wet lipid
bilayer. Fluorescence microscopy images taken at different areas in the sample revealed
that the presence of the bilayer induced the aggregation of the peptide (Figure 6.8). To
further explain the appearance, it is hypothesized that the Aβ picks up some NBD-PC as
it forms aggregates. To determine whether the prepared lipid bilayers maintained its
dynamic properties on the mica support, its lateral diffusion was measured by FPR.
Figure 6.9 shows the trend in the diffusion coefficient of NBD-PC in a bilayer with
POPC as a function of time. Two diffusion modes which differed by orders of magnitude
were calculated. The slow mode was dominant with about 80% of the signal amplitude.
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There was almost no change in the diffusion coefficient for the duration of the
experiment.

a)

b)

50 µm

50 µm

d)

c)

50 µm

50 µm

Figure 6.8. Fluorescence microscopy images showing the interaction of unlabeled βamyloid peptide with supported phospholipid bilayers on mica. (a-d) changes in the lipid
membrane at different regions in the sample.
The interaction of Aβ was further investigated with lipid vesicles in suspension.
Figure 6.10 shows the diffusion values as a function of time. In contrast to the results
obtained for the interaction of Aβ with lipid bilayers only one diffusion mode was
obtained. The diffusion coefficient was only slightly lower than that of the vesicles alone.
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Figure 6.9. FPR diffusion coefficient values of NBD-PC in the presence of β-amyloid on
mica-supported lipid bilayer as a function of time. The percent of fast and slow signal
amplitude are displayed.
6

5

3

-8

D/10 cm s

2 -1

4

2

1

NBDPC POPC (Extrusion)
NBDPC POPC + Abeta oligomeric peptide (1:10)

0
0.0

0.5

1.0

1.5

2.0

Time /Days

Figure 6.10. Diffusion of NBD-PC in vesicles composed of NBD-PC/POPC (5/95 mol
percent) in the presence of preformed β-amyloid1-40 fibrils (1:10 molar ratio).
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Like the results obtained for the interaction of Aβ with lipid bilayers, there was almost
almost no change in the diffusion value as a function of time. These later results are
consistent with findings in the literature that the Aβ does not alter the properties of
zwitterionic lipid vesicles.
6.8.3 Fluorescence Imaging and FPR Analysis of Interaction of Melittin with Lipid
Bilayers
Melittin was chosen as a control molecule due to its profound ability to affect the
properties of natural, as well as negatively charged and zwitterionic, phospholipid
artificial membranes. FPR was used to determine whether melittin induced any changes
in the dynamic properties of the lipid bilayer on a mica support. Figure 6.11 shows the
trend in the diffusion value as a function of time.
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Figure 6.11. FPR diffusion coefficient of NBD-PC in the presence of melittin on micasupported lipid bilayer as a function of time. The percent of fast and slow signal
amplitude are displayed.
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The results are almost identical to those obtained for the interaction of Aβ with lipid
bilayers, with the expection being that the percent signal amplitude was lower by almost
20% for the slow diffusers. Additional experiments were performed to investigate the
interaction of melittin with lipid vesicles.

a)

b)

Figure 6.12. Fluorescence microscopy image showing the interaction of melittin with
vesicles composed of 5% NBD-Labeled PC/95% unlabeled POPC (1:1 molar ratio). (a)
after 3hrs, (b) after 7.5 hrs.
Figure 6.12 shows fluorescence microscopy images of a one to one molar ratio of melittin
with lipid vesicles at 3 and 7.5 hours after sample preparation. The initial presence of
small spherical vesicles shown in white against a green background is observed in Figure
6.12a. The growth of the vesicles became more apparent after 7.5 hours. The trend in the
diffusion values as a function of time is shown in Figure 6.13. The fact that the sample
was a polydisperse population of several species is clearly demonstrated by the multiple
exponential analysis results and better yet by the 3-D representation of the CONTIN
distribution of the data in Figure 6.13 bottom.
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Figure 6.13. Top: Diffusion of NBD-PC in vesicles composed of NBD-PC/POPC (5/95
mol percent) in the presence of melittin. Bottom: 3-D representation of CONTIN
distribution of data.
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Figure 6.14. Contrast of melittin at zero and 7.5 hours in lipid vesicles.
The deviation from single exponentiality of the signal contrast at time 3 and 7.5 hours in
Figure 6.14 also suggests accurate analysis of the sample composition. Unlike the Aβ
peptide, the results clearly show that melittin interacts with zwitterionic lipid vesicles and
induces swelling of the vesicles.
6.9 Conclusions
FPR was used to investigate the effect of Aβ on membrane fluidity. For
comparison, melittin was chosen as a control molecule as it has been found to induce
changes in the dynamic properties of lipid bilayers. The results from initial FPR
experiments for the diffusion of tracer lipid molecules composed of the fluorescent lipid
probe, 1-Oleoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-snGlycero-3-Phosphocholine (NBD-PC) and 1-palmitoyl-2-oleoyl-sn-glycero-3phosphocholine (POPC) at a ratio of 5% NBD-PC to 95% POPC (supported on mica)
was consistent with diffusion coefficient values reported for phospholipids molecules in
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fluid bilayers. Upon incubating the Aβ on the bilayers, there was a marked decreased in
the diffusion coefficient values, indicating that the presence of the fibrils hindered the
diffusion of the lipid probe, suggesting that the Aβ acts to decrease the fluidity of the
lipid membrane. Fluorescence microscopy images revealed that the Aβ peptide perturbs
the composition of the bilayers and increased aggregation of the peptide was observed. In
studies examining the interaction of Aβ with zwitterionic lipid vesicles, there was no
change in the diffusion values. The melittin control on the other hand, vastly induced the
aggregation of the lipid vesicles. This suggests that bilayer surface may play a pivotal
role in the Aβ aggregation mechanism. Perhaps, the lipid membrane is acting as a
nucleation site for initiating the aggregation of the Aβ peptide.
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APPENDIX A: FLUORESCENCE SPECTROSCOPY
Table with sample identification using a 96-well plate layout.
1
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3
4
5
6
0.1 µM
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0.1 µM
A 50mM 0.1 µM 25 µM
PBS,
Labeled unlabeled Labeled
Labeled
Labeled
150
Aβ
Aβ
Aβ + 25 Aβ + 25 Aβ + 25
mM
µM
µM
µM
NaCl,
unlabeled unlabeled unlabeled
pH
Aβ
Aβ + 25 Aβ + 25
7.4
µM
µM
Amy1
Amy2
(0.1:1)
(0.1:1:1) (0.1:1:1)
B
0.1 µM
0.1 µM
0.1 µM
C 50mM 0.1 µM 0.1 µM
PBS,
Labeled Labeled
Labeled
Labeled
Labeled
150
Aβ
Aβ + 25 Aβ + 25 Aβ + 25 Aβ + 25
mM
µM
µM
µM
µM
NaCl,
unlabeled Amy1
Amy2
Modified
pH
Aβ
7.4
(0.1:1)
(0.1:1)
(0.1:1)
(0.1:1)
D
0.1 µM
0.1 µM
0.1 µM
E 50mM 0.1 uM 0.1 uM
PBS,
Labeled labeled
Labeled
Labeled
Labeled
150
Aβ
Aβ + 25 Aβ + 25 Aβ + 25 Aβ + 25
mM
µM
µM
µM
µM
NaCl,
unlabeled unlabeled unlabeled unlabeled
pH
Aβ
Aβ + 50 Aβ + 50 Aβ + 50
7.4
µM
µM
µM
Amy1
Amy2
Modified
(0.1:1)
(0.1:1:2)
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(0.1:1:2)

(0.1:1:2)

7
0.1 µM
Labeled
Aβ + 25
µM
unlabeled
Aβ + 25
µM
Modified

8
0.1 µM
Labeled
Aβ + 25
µM
unlabeled
Aβ + 25
µM
Murphy

9
0.1 µM
Labeled
Aβ + 25
µM
unlabeled
Aβ + 25
µM
Meredith

(0.1:1:1)

(0.1:1:1)

(0.1:1:1)

0.1 µM
Labeled
Aβ + 25
µM
Murphy

0.1 µM
Labeled
Aβ + 25
µM
Meredith

(0.1:1)

(0.1:1)

0.1 µM
Labeled
Aβ + 25
µM
unlabeled
Aβ + 50
µM
Murphy

0.1 µM
Labeled
Aβ + 25
µM
unlabeled
Aβ + 50
µM
Meredith

(0.1:1:2)

(0.1:1:2)

A screen capture of fluorescence spectroscopy results plotted in an Excel spreadsheet
using FLUOstar Galaxy software.
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APPENDIX B: HIGH PRESSURE INSTRUMENTS
High Pressure Cell Set-up
Both vial and cap are filled with the sample and
covered – care should be taken to avoid air bubbles.
The vial is subsequently inserted into a sample holder
within the ethanol filled high pressure cell chamber.

Photograph of high pressure cell set-up (Location A, UNICAMP, Campinas, Sao Paulo,
Brazil)
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The high pressure cell is then placed
within a modified Edinburg FL 900
spectrofluorometer chamber and the pressure
generator connected to the top of the cell.

Photograph of high pressure cell set-up (Location A, UNICAMP, Campinas, Sao Paulo,
Brazil)
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Photograph (courtesy of Dr. Rafael Cueto) of high pressure cell set-up (Location B,
Louisiana State University, LA)
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Photograph (courtesy of Dr. Rafael Cueto) of high pressure cell set-up (Location B,
Louisiana State University, LA)
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